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Abstract 
 
 Membrane proteins are important therapeutic targets which play vital roles in cellular 
function. As protein structure is closely linked to its function, the characterization of membrane 
proteins is vital to elucidating their involvement in disease and potential druggability. Despite this, 
membrane proteins are underrepresented in structural databases due to challenges associated with 
their hydrophobicity and difficulty in obtaining high purity samples. There is an imminent need 
for methods to study the dynamic structure, folding, and ligand interactions of membrane proteins. 
Native mass spectrometry (MS) has emerged as a method capable of handling the polydispersity 
of membrane proteins samples to yield details of their structure and function. Particularly, ion 
mobility MS (IM-MS) has shown promise in assessing the organization of membrane protein 
complexes and, through collision induced unfolding (CIU) experiments, the relative stability of 
gas phase membrane proteins. However, challenges remain in developing robust, high-throughput 
methods for the study of membrane proteins through IM-MS. 
 In Chapter 2, we develop a workflow for studying ligand binding of the integral 
translocator protein (TSPO) with the aim of revealing the identity of an endogenous ligand. As 
part of this workflow, a system for automated de-noising of CIU fingerprints is presented, allowing 
for the quantitative stability characterization of eight different lipids and ligands. For the first time, 
quantitative CIU measurements of stability and classification are used to determine that the ligands 
endogenously bound to TSPO are a mixture of phospholipid isoforms bearing the PG head group. 
In Chapter 3, we present a workflow for elucidating key differences among disease associated 
protein variants through IM-MS. Seven mutant forms of peripheral myelin protein (PMP22) are 
 xv 
 
shown to possess differences in dimer formation and gas phase stability that correlate with 
previously published data about cellular trafficking and disease state. Further, from our analysis, 
we construct a potential mechanism of how dysregulation of PMP22 leads to disease in which 
mutations cause destabilization of PMP22 monomers leading to the formation of dimeric 
complexes that are poorly trafficked in cells. In Chapter 4, we present methods to study three 
mutant forms of the voltage sensing domain of the KCNQ1 potassium channel. We find that CIU 
of the KCNQ1 mutants classify well according to their observed level of trafficking in cells, 
indicating a role for specific structural triggers in KCNQ1 trafficking. The function-based 
classification represents a more broadly applicable method for studying structure differences in 
proteins with many known mutations. 
 In Chapter 5, we explore the fundamental relationship between membrane protein 
solubilization techniques and IM-MS. The integral transmembrane proteins, PMP22 and TSPO, 
and a monotopic membrane protein, cytochrome P450 3A4, are prepared in multiple solubilization 
techniques, including micelles, bicelles and, nanodiscs. Noticeable differences in oligomerization 
are found for TSPO samples liberated from detergent micelles and nanodiscs, and for shifts in the 
observed charges states are noted. Upon CIU analysis of the complexes, we find that differences 
in unfolding trajectories and gas phase stability exist for both PMP22 and CYP3A4 when liberated 
from the varying solubilization agents, which we interpret to relate to the local protein 
environment. Our experiments do not show that one solubilization method is universally superior 
at preserving the gas phase structure of membrane proteins as each protein system had different 
patterns of compaction in terms of CCS, number of CIU transitions, and stability across the 
solubilization methods.   
  1 
Chapter 1 Introduction 
 
Membrane proteins play vital roles in many cellular functions including cell signaling, 
transport, and enzymatic reactions. Embedded in biological membranes, these proteins exist in 
complex environments, where interactions with lipids, sterols, and other proteins regulate their 
function.1 Additionally, the folding and structure of membrane proteins are  intimately linked to 
their environmental interactions.2 Methods to study membrane proteins are essential to 
understanding how they perform their cellular functions and, as many membrane proteins are 
implicated in disease states, how pharmaceuticals may be developed to correct their dysfunction.3 
However, due to their insolubility in aqueous solutions and the complex environments in which 
they exist natively, membrane proteins are challenging analytes. Here I review some of the general 
properties, challenges, and methods for studying membrane proteins, with an emphasis on native 
ion mobility mass spectrometry (IM-MS), which is the focus of this dissertation. 
 
1.1 Membrane proteins and human disease 
Membrane proteins represent over 60% of therapeutic drug targets and nearly 80% of drugs 
approved by the FDA act on membrane proteins.3 These therapeutic protein targets vary widely in 
structure, function, and the types of diseases they are implicated in. One example of a well 
characterized membrane protein target is the serotonin transporter, on which multiple classes of 
antidepressants act. The role of the serotonin transporter in depression,4,5 its structure and mode of 
drug binding,6–9 and its protein-protein interactions have all been reported.10 Contrastingly, for 
  2 
many other membrane proteins implicated in disease much less is understood about their exact 
biological roles and how disruption of these roles cause disease states.  One example of this is the 
mitochondrial 18 kDa Translocator Protein (TSPO), which is implicated in a range of illnesses 
including neuroinflammation,11,12 cancer,13,14 and cardiovascular disease,15  based on changes in 
its expression levels and  the observation of disease-correlated mutations. While TSPO is proposed 
to be involved in the transport of cholesterol and porphyrin, researchers are actively working to 
elucidate TSPO-related disease eitologies.16 Peripheral myelin protein 22 (PMP22) is another 
example of a membrane protein where mutations have been correlated to a range of disease states, 
including Charcot-Marie-Tooth 1,17–19 but the mechanism by which these mutations lead to various 
forms of neuropathy is not wholly understood.20 For both TSPO and PMP22, no FDA approved 
drugs currently exist.  
 
1.2 Structure of membrane proteins 
Membrane proteins can be classified broadly into two categories, integral and peripheral, 
based on the way they interact with the membrane.21 Peripheral proteins do not embed in the 
membrane and instead interact with 
the polar lipid head groups on the 
surface of the membrane in a 
reversible fashion, as seen in Figure 
1-1. Integral proteins have one or 
more regions of the protein 
embedded in the membrane and 
interact with the hydrophobic tails of the lipids in the bilayer in addition to the polar lipid head 
Figure 1-1. Types of membrane proteins. Integral proteins embed in the lipid 
bilayer while peripheral proteins interact with only the surface of the 
membrane. Transmembrane integral proteins span the entire membrane and 
monotopic integral proteins only penetrate part of the bilayer.  
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groups. Integral proteins can be further divided into classes of transmembrane, which span the 
entire length of the bilayer, and monotopic proteins, which permanently associate only with one 
leaflet of the bilayer. For transmembrane proteins, the structure of the regions within the membrane 
contain either α-helical or β-strand motifs, often rich in hydrophobic residues.22–24 These motifs 
commonly manifest as α-helical bundles and β-barrels when multiple membrane spanning domains 
are present.  
Transmembrane proteins are uniquely suited to perform several functions in the cell 
including transporting ions and conveying signals across the lipid bilayer. Accordingly, most 
transmembrane proteins fall into one of three functional categories: transporters, receptors, and 
enzymes (Figure 1-2).25 As biological membranes are generally impermeable to most polar 
molecules, transporter proteins are key for regulating the flow of molecules in and out of cells and 
organelles.26 Families of transporters are sensitive to different environmental conditions, such as 
voltage gated ion channels which respond to charge differences across the membrane.27 All 
transporters characterized thus far pass through the membrane multiple times and are thus multi-
pass transmembrane proteins. The receptor category of transmembrane proteins is  responsible for 
initiating cellular responses upon specific ligand binding.28 G-protein coupled receptors (GPCRs) 
Figure 1-2. Transmembrane protein functional classes. From left to right: top-down and membrane view of a tetrameric voltage 
gated potassium channel (PDB 6EBM), membrane view of a β-2 adrenergic receptor GPCR (PDB 5D5A), membrane view of a 
bitopic cytochrome p450 (PDB 4LXJ).  
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are one family of receptor transmembrane proteins of great importance to the pharmaceutical 
industry, as 33% of all small molecule drugs target this protein class.3. While GPCRs are multi-
pass proteins with seven transmembrane domains, some transmembrane receptor proteins pass 
through the membrane only once, referred to as bitopic or single-pass proteins.25 Membrane 
enzymes are often bitopic proteins, including many of the cytochrome P450 monooxygenases that 
are responsible for metabolizing many small molecules.29,30 Note that cytochrome P450s can also 
be monotopic (e.g. CYP 3A4).31   
 
1.3 Membrane proteins are challenging analytes 
Despite their importance, membrane proteins are understudied in comparison to their soluble 
counterparts.32 This is due to a combination of factors that make membrane proteins challenging 
analytes. Membrane proteins are difficult to express and purify, which can lead to low yields and 
impure protein samples which are not amenable to traditional biophysical techniques for structure 
determination.33,34 Additionally, the intrinsic hydrophobicity of membrane proteins makes them 
poorly water soluble and unable to retain their native structure in aqueous solution.  As such, a 
solubilization method must typically be employed to mimic their native hydrophobic environment 
in order to carry out detailed structure and function characterization efforts.35,36 Further 
complicating the study of membrane proteins is the complexity of their native environment, where 
they may interact with other proteins,37 endogenous ligands,38,39 or lipids.40,41 These challenges 
have all contributed to the dramatic underrepresentation of membrane proteins in structural 
databases.42  
 
 
  5 
1.3.1 Solubilization methods 
To conserve the native structure of membrane proteins in the absence of a cell membrane, 
multiple solubilization techniques have been developed. The three methods used in this thesis: 
detergent micelles, bicelles, and nanodiscs, are shown in Figure 1-3. Historically, detergent 
micelles have been the most popular technique for solubilizing purified membrane proteins and 
they remain widely used today.34,42 Detergents can have varying structures and charge, but all 
possess the ability to form a micelle above certain critical concentration.33 This concentration is 
referred to as the critical micelle concentration or CMC in membrane protein purification and 
analysis protocols.  With the optimization of the detergent choice, concentration, and solution 
conditions, a membrane protein can be encapsulated within detergent micelles, wherein 
hydrophobic protein residues interact with hydrophobic parts of the detergent and the polar head 
groups of the detergent solubilize the complex. 42,43  
 
Figure 1-3. Solubilization techniques for membrane proteins employed in this work. 
More complex solubilization methods aim to better mimic the native environment of 
membrane proteins through creating a lipid bilayer. There are many approaches to create this 
bilayer, each with  advantages and disadvantages,44–46 but only bicelles and nanodiscs will be 
described. In both bicelles and nanodiscs, the membrane protein is encapsulated by a lipid bilayer, 
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which consists of one or more lipid type. In bicelles, detergents are used to surround the edges of 
the bilayer to create a fluid, yet discrete, bilayer structure.47 In nanodiscs, a scaffold protein or 
peptide is used in lieu of detergents.48 For both methods, the thickness of the bilayer,49 overall 
sizes of the particles,48,50 and composition of lipids in the bilayer51,52 can be optimized for protein 
incorporation.  
 
1.3.2 Membrane proteins are underrepresented in structural databases 
It is estimated that up to 30% of proteins in eukaryotic cells are membrane proteins, but only 
a small fraction of these proteins have solved structures in 
databases.32,33,53 For example, as of 2015, only 3% of unique structures 
in the Protein Data Bank (PDB) were membrane proteins.54 Protein 
structure is intimately linked to function,55 and thus correcting this 
disparity has been a major area of research over the last few decades. 
Towards this end, membrane protein specific structural databases have 
been created in addition to the PDB, including mpstruc,56 Orientations 
of Proteins in Membranes (OPM),57 and PDBTM.58 These databases 
contain almost 12,000 unique membrane protein structures. 
Advances in structure determination techniques, specifically through 
advances in electron microscopy (EM), have allowed the proportion of transmembrane (TM) 
proteins in structural databases to eclipse that of monotopic and peripheral proteins combined, as 
shown in Figure 1-5.32 Transmembrane α-helical proteins comprise 57% of total reported 
structures across all databases, while β-barrel structures comprise only 11%, which loosely 
translates to their expected representation in the mammalian proteomes.32,53,59 It is important to 
Figure 1-4. Percentage of membrane 
proteins in the eukaryotic proteome 
and percentage of membrane 
proteins in the PDB. 
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note that for all of these reported structures, the full 
transmembrane region or protein sequence is not 
necessarily present. Some may also include engineered 
additions to the protein that aim to increase the proteins 
stability or amenability to the structure determination 
technique, which may or may not alter  protein 
structure.60  
 
1.4 Biophysical techniques for studying membrane protein structure 
The  majority of membrane protein structures entered across the PDB and membrane 
specific databases were obtained through X-ray crystallography.32 In X-ray crystallography, a 
purified protein is first crystallized and then subjected to X-ray diffraction analysis. The pattern 
formed during diffraction is then used 
to map the electron density of the 
crystal, allowing for production of 
atomic resolution 3D structures. For 
membrane proteins, this process is 
complicated by both the difficulty of 
forming crystals from membrane 
proteins and the typically low purity 
and concentration of membrane proteins.33 A major advancement enabling the success of 
membrane protein crystallography was the development of lipid cubic phase (LCP) 
methodologies,61 which has enabled the structural determination of membrane protein complexes, 
Figure 1-6. Percent of membrane protein structure reported in databases 
by method per year. Adapted with permission from Shimizu et al. 2018.  
Figure 1-5. Percentage of total membrane protein 
structure entries across four databases. 
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such as the beta-2-adrenegic G protein complex.62 Ligands or lipids interacting with membrane 
proteins have also been observed through this method, however, the electron density alone is not 
always sufficient to identify these small molecules.14  
As mentioned above, the number of membrane protein structures derived from EM 
methods has significantly grown over the past 5 years (Figure 1-6).32 In this method, a crystal is 
not required and individual particles are placed in a grid, or within vitrified ice (cryoEM), 
irradiated with electrons. The structures produced by cryoEM can possess comparable resolution 
to those produced by X-ray crystallography, however, the success of this approach is limited for 
proteins under 100 kDa.63–65 Conversely, nuclear magnetic resonance spectroscopy (NMR), where 
radio frequencies are used to excite nuclear spin states for atoms within a protein sample and the 
observed shifts in observed spin frequency are used to measure atomic proximity, can be used to 
study the dynamics of membrane proteins up to approximately 40 kDa.66 In NMR, a crystal is not 
required and multiple protein conformations can be observed leading to measurements capable of 
capturing dynamic protein motions, but pure and homogenous samples are still required. Both EM 
and NMR are also compatible with membrane proteins solubilized in lipid bilayer mimetics such 
as bicelles and nanodiscs.67–69 In light of the challenges associated with high resolution structural 
techniques, a plethora of spectroscopic and biophysical assays have been developed to study the 
structure membrane proteins,42 including surface plasmon resonance,70 circular dichroism,71 and 
fluorescence assays.72 
1.5 Mass spectrometry of membrane proteins 
Mass spectrometry has recently emerged as a method especially suited for the analysis of 
native membrane proteins, due in part to its ability to handle complex mixtures and lower sample 
concentration requirements.52,54,73–76 In MS, analytes are ionized and transported to a mass 
  9 
analyzer and detector. The ionization of membrane proteins has been mainly performed through 
electrospray ionization (ESI) and matrix assisted laser desorption ionization (MALDI),77 however 
for the purposes of this work we will focus on ESI methodologies, which dominate the analysis of 
native protein samples. ESI can be used to study denatured, yet intact, membrane proteins or 
peptides generated through protein digests of membrane proteins. In contrast, native MS of 
membrane proteins, where the 3D structure of the membrane protein is left largely unchanged, can 
be optimally performed through nano-electrospray ionization (nESI), where smaller droplets are 
produced and heating of the sample is typically not needed to initiate ionization. Membrane protein 
ions generated through ESI or nESI for native MS analysis are most often still encapsulated in 
within solubilization agents, and therefore collisional activation must be applied to remove bound 
detergents or lipids from the target membrane protein ion.78 Additionally, the independent 
solubilization agents themselves, e.g. detergents, also ionize and can thus result in an abundance 
of noise signals in the resulting native mass spectra. While time-of-flight (ToF) mass analyzers 
have shown great success in this field, higher resolution technologies, such as Orbitrap mass 
analyzers, can be helpful for resolving such noise signals from intended membrane protein 
analytes.  
Figure 1-7. Nanoelectrospray ionization (nESI) of membrane proteins. In addition to membrane proteins encapsulated in their 
solubilization techniques, the solubilization agents themselves can ionize. 
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1.5.1 Structural proteomics, labeling, and lipidomics 
Proteomics, the organism-wide study of protein expression, can be used to identify 
membrane proteins through their sequence,59 elucidate post-translational modifications,79 and 
reveal interactions between membrane proteins. MS-based proteomics methods typically identify 
peptide fragments originating from larger proteins through their measured mass and sequencing 
information derived from tandem MS (MS/MS) methodologies, where one m/z is selected within 
a first mass analyzer and then fragmented using a variety of activation techniques prior to second-
stage mass analysis. Overall, proteomics methods can be divided into those that approach the 
problem from a bottom-up perspective, where peptides are generated by digestion of a protein in 
solution are the primary analytes, and those that analyze proteins in a top-down frame of reference, 
where denatured proteins are the primary analytes, and identification is highly dependent on  
fragment ions generated within the mass spectrometer. Although proteomics has been widely used 
to study soluble proteins, the low expression level of many membrane proteins, incompatibility 
with traditional urea based denaturation techniques, and a limited number of charged residues with 
their sequences have hampered the success of membrane proteomics.77 Additionally, the 
detergents used to solubilize membrane proteins can create abundant noise signals in the mass 
spectra and, particularly for top-down proteomics, require additional energy within the instrument 
to remove from the intended analytes. Advancements in membrane enrichment techniques,80,81 
detergent removal steps,82 and development of MS compatible detergents83 have all aided the 
progress of this field in recent years. However, the current technology is not sufficient to 
characterize the diverse membrane proteome in its entirety,59 and the study of native membrane 
proteins through proteomics is still an active area of research with relatively few published 
manuscripts.84 
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Deeper structural insights can be gained from membrane protein digests through labeling 
techniques, where the solvent accessible sites of a native protein in solution are labeled 
permanently or reversibly prior to digestion. Hydrogen-deuterium exchange (HDX), chemical 
crosslinking, and fast photochemical oxidation (FPOP),85 have all been used to probe the tertiary 
structure and interactions of membrane proteins with proteins86 and solubilization agents.87 
 As lipids are known to interact with and change the functionality 
of membrane proteins,41,74,88 lipidomics is an important field adjacent to 
membrane proteomics. While lipids are much smaller than proteins, they 
are vastly complex with over 40,000 biological lipids cataloged in the 
database LIPID MAPS.89 A challenge for MS-based lipidomics 
techniques is that some lipids are isobaric, and therefore cannot be 
differentiated by intact mass alone. MS/MS methods  can be employed 
to enhance the identification of lipids, including some which are 
isobaric.90 Databases and software have been curated using libraries of 
known MS/MS spectra to assist in the identification of lipids.91,92 One 
limitation of lipidomics in respect to structural membrane protein 
analysis is that lipids observed to co-purify with membrane proteins may 
or  may not represent evidence of functional protein-lipid complexes. 
Additionally, information on where such lipids interact with the protein, their stoichiometries, and 
binding strengths cannot be directly obtained through these experiments alone. 
  
 
 
Figure 1-8. Examples 
phospholipids illustrating the 
diversity among lipids in both 
head group (orange) and chains 
(blue).   
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1.5.2 Native ion mobility - mass spectrometry 
Recently, native MS has been shown to be a powerful tool for probing membrane protein 
structure and function.54,74,75,93,94 After nESI, membrane proteins can be liberated from a variety 
of detergent and solubilization agents in the gas phase using different techniques for activation, 
such as collision induced dissociation (CID). It is important to note that not all solubilization agents 
are equally effective in this endeavor, and screening detergents, solution conditions, and 
optimizing instrument parameters is a necessity for striking the delicate balance between the 
removal of solubilization agents and retention of native structure.95 However, with successful 
optimization, native MS has been used to study discrete lipid binding,74,94,96 ligand binding,97 and 
specific protein-protein interactions associated with a wide range of membrane proteins.52,75,98 
The addition of an ion mobility separation to mass spectrometry instruments (IM-MS) is 
beneficial for native MS of membrane proteins.  IM separates protein ions according to their size 
and shape by recording their drift through a neutral buffer gas under the influence of a weak electric 
Figure 1-9. Instrument diagram of an IM-MS instrument, Synapt G2 (Waters, Milford MA). After nESI, membrane proteins are 
transported through the quadrupole still encapsulated in their polydisperse solubilization agents. Membrane proteins are liberated 
from the agents in the trap collision cell and then separated in a travelling wave IM cell. Additional energy can be added in the 
transfer collision cell to dissociate clusters of solubilization agents before time-of-flight mass analysis. 
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field.  The output of IM analyses is often the determination of collision cross section (CCS), or the 
orientationally averaged size, of ions which can be compared to cross sections calculated from 
structures found within in databases or produced through molecular dynamics simulations.99 
Additionally, IM-MS platforms, such as the Waters Synapt G2 (Milford, MA, USA) used in this 
work (Figure 1-9), include supplemental trapping regions that  provide opportunities to perform 
CID for both liberation of membrane proteins from their solubilization agents and breaking up free 
clusters of solubilization agents, which can greatly increase signal quality.  
The energy experienced by ions in these trapping regions is a function of an accelerating or 
collision voltage (CV), and, ideally, optimized solubilization systems can be removed at relatively 
low CVs. At CVs higher than the threshold for removal of the solubilization agents, the membrane 
protein can experience collision induced unfolding (CIU), and this unfolding can be tracked 
through the resulting IM arrival time distribution.100 As seen in Figure 1-10, these data can be 
plotted as CIU fingerprints with CV on the x-axis and arrival time on the y-axis with intensity 
indicated by a color scale. Recent software developments allow for the automated detection of 
features, or regions of conformational stability in CV space, as well as the fitting of sigmoidal 
Figure 1-10. Collision induced unfolding (CIU). The arrival time distribution (ms) for a specific m/z is extracted from the IM-
MS data set. As the CV is ramped in the trap of the instrument the protein unfolds, which can be visualized through CIU 
fingerprints. Software allows for automated analysis of CIU fingerprints including the detection of features and generation of 
sigmoidal fits between features yielding CIU50 values.   
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functions between features to output discrete values where transitions occur (CIU50 values).101 
CIU experiments are valuable for assessing the relative gas phase stability of membrane protein 
complexes74,102 and have been used in the past to classify soluble protein systems.73 Despite the 
successful characterization of a range of membrane protein systems, many IM-MS and CIU 
datasets reported in the literature exhibit solubilization agent related noise,40,103 and currently, 
membrane protein CIU has only been demonstrated with protein liberated from detergent micelles.  
Methods for minimizing and handling detergent, lipid, and scaffold related noise are key to 
enabling CIU of membrane protein solubilized in more complex lipid mimetics. 
IM-MS methods for studying membrane proteins and membrane protein complexes have 
sample concentration requirements in the low nanomolar range, which is significantly lower than 
high resolution structural techniques such as X-Ray crystallography.61,95 IM-MS is also compatible 
with many different membrane protein solubilization methods over a broad range of protein 
sizes.104 While IM-MS methods have been shown to yield dynamic information on membrane 
protein structure, atomic level protein structure cannot be solved through IM-MS alone, and thus 
IM-MS methods are often combined with traditional biophysical techniques.105,106 Additionally, 
membrane protein IM-MS and CIU are still relatively new fields, both gaining popularity within 
the last decade, and their full potential is still actively being explored.100  
 
 
1.6 Summary 
This thesis focuses on developing and applying IM-MS methodologies to 
pharmaceutically relevant membrane proteins. It can be divided into two parts: 1) developing and 
applying workflows for elucidating biologically relevant information from therapeutic targets 
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through IM-MS and 2) exploring the fundamental effects of membrane proteins solubilization 
agents on gas phase protein structure and unfolding. 
Chapters 2, 3, and 4 are aimed at studying the structural biology of therapeutically 
relevant membrane proteins. In Chapter 2, a workflow for de-noising of CIU fingerprints and the 
identification of an endogenously bound ligand to TSPO is revealed. This work has been 
published as Fantin, S. M, Parson, K. F., Niu, S., Liu, J., Polasky, D. A., Dixit, S. M., 
Ferguson-Miller, S. M., and Ruotolo, B. T. Collision Induced Unfolding Classifies Ligands 
Bound to the Integral Membrane Translocator Protein. Anal. Chem. 2019, 91 (24), 15469-
15476. Chapter 3 elucidates a possible mechanism of disease for mutant forms of PMP22 
through observed differences in protein oligomeric state and gas phase stability. In Chapter 4, 
gas phase unfolding of mutant forms of the voltage sensing domain (VSD) of KCNQ1 is 
demonstrated as a means to classify mutants according to their cellular trafficking behavior. 
Chapter 5 focuses on the effects of solubilization technique, namely micelles, bicelles and 
nanodiscs, on gas phase protein structure and unfolding.  We find that there are significant 
differences in protein oligomeric state, charge state, and unfolding trajectories when such 
analytes are prepared using different solubilization techniques, which calls into question how 
such agents should be used to preserve native membrane protein structure in general. In Chapter 
6 we conclude by summarizing our findings and their impact on the field of nMS, and we 
propose future directions related to high throughput screening and the expansion of the 
solubilization agent study described in Chapter 5. 
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Chapter 2 CIU Classifies Ligand Binding of Integral Membrane Translocator Protein 
(TSPO) 
 (Adapted with permission from: Sarah M. Fantin, Kristine F. Parson, Shuai Niu, Jian Liu, 
Daniel A. Polasky, Sugyan M. Dixit, Shelagh M. Ferguson-Miller, and Brandon T. Ruotolo. 
Collision Induced Unfolding Classifies Ligands Bound to the Integral Membrane Translocator 
Protein. Analytical Chemistry 2019 91 (24), 15469-15476. Copyright 2019 American Chemical 
Society.) 
 
2.1 Introduction 
Membrane proteins play central roles in cellular signaling, molecular trafficking, and a 
wide variety of enzymatic reactions.107 As such, membrane proteins represent a disproportionately 
large number of current drug targets with respect to their predicted abundance in the human 
genome.108,109 Despite their importance, the poor solubility of membrane proteins in aqueous 
solvents often limits their expression and purification yields,35,110  resulting in a deficit of 
membrane protein structural knowledge.  Specifically, membrane proteins currently comprise only 
3% of unique entries in the Protein Data Bank.54 Recent advancements in NMR, X-Ray, and EM 
methods have moved to close this gap; however, many challenges remain in assessing membrane 
protein dynamics, polydispersity, and ligand binding in a high-throughput manner.111–114  
Recently, native mass spectrometry (MS) has been deployed to address the unique 
challenges associated with studying the structure and function of membrane proteins. Typical 
experimental workflows involve the micellar solubilization of membrane proteins, the use of nano-
electrospray ionization (nESI) to produce micelle-protein complex ions, and the subsequent 
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breakdown of detergent micelle ions using collisional activation to reveal membrane protein as 
well as smaller surfactant cluster ion populations.  Insights into membrane protein complex 
organization,84,115,116 lipid binding,96,117,118 and membrane mimetic performance52,118–121 have been 
gained by leveraging the ability of MS to manage the complex mixtures that typically result from 
this workflow. Ion mobility-mass spectrometry (IM-MS), which sorts ions according to both their 
orientiationally-averaged size and m/z ratio, can be used to capture large, global changes in 
membrane protein structure associated with their function.122 IM-MS enables the use of collision 
induced unfolding (CIU), where collisional activation is utilized to unfold isolated protein ions in 
the gas phase. CIU of membrane proteins can be sensitive to ligand binding, and  gas-phase 
stability shifts have been linked to lipid binding selectivity.106,123,124 Despite these successes, many 
challenges hinder the broader implementation of CIU methodologies for membrane protein 
complexes. Generating tandem MS of sufficient quality and detail to identify ligands ejected from 
membrane proteins is currently difficult, if not impossible, to achieve. In addition, chemical noise 
generated by protein solubilization agents can overlap with signals associated with small 
membrane protein ligand complexes, creating a convoluting signal population within CIU 
fingerprints and obfuscating key stability information. 
An example of one such small membrane protein complex is the 36 kDa dimer of 
translocator protein (TSPO), which plays key roles in stress response, cancer,  neurodegenerative 
conditions, and cardiovascular diseases13,15,125,126. Multiple classes of ligands have been proposed 
to bind to specific regions of the  TSPO surface, including cholesterol, protoporphyrin, lipids, and 
small drug-like molecules.127,128 Despite its plurality of proposed ligands, TSPO is still an orphan 
receptor, in that there is currently no consensus regarding the identity of its endogenous ligands, 
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and many questions remain surrounding the potential allosteric impact of ligand binding on TSPO 
structure.129 
Here, we develop CIU data analysis strategies and deploy these techniques to characterize 
TSPO-ligand complexes. We quantify stability shifts associated with lipid and porphyrin binding 
to TSPO, and observe a stronger stability shift upon protoporphyrin IX (PPIX) binding when 
compared to any of the lipid complexes we detect. Furthermore, we build a CIU classification 
scheme capable of differentiating two sets of TSPO:ligand complexes by their proposed binding 
region. Finally, we utilize CIU fingerprint classification and high resolution mass spectrometry 
(HRMS) to characterize an endogenous TSPO ligand, putatively identifying the bound material as 
a mixture of phosphotidylglycerol (PG) isomers having different levels of chain saturation.  We 
conclude by discussing the general utility of our enhanced CIU methods for the study of membrane 
protein complexes. 
 
2.2 Methods 
 
2.2.1 Membrane Protein Sample Preparation 
TSPO bearing the A138F point mutation was purified and expressed using established 
protocols from Rhodobacter sphaeroides.128 All lipids (1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine [PE], 1',3'-bis[1,2-dimyristoyl-sn-glycero-3-phospho]-glycerol [CDL], 1-
palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine [PS], 1-palmitoyl-2-oleoyl-glycero-3-
phosphocholine [PC], 1,2-dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol) [PG], 1,2-
dipalmitoyl-sn-glycero-3-phospho-(1'-myo-inositol)[PI], and 1,2-dioleoyl-sn-glycero-3-
phosphate[PA]) were purchased from Avanti Polar Lipids (Alabaster, AL). Ammonium acetate, 
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Protoporphyrin IX, Octyl β-D-glucopyranoside (OG), and chloroform were purchased from Sigma 
Aldrich (St. Louis, MO). Isopropanol and methanol were purchased from Fisher Scientific 
(Hampton, NH).  For all native MS experiments, 30 μM TSPO was buffer and detergent exchanged 
simultaneously from 50 mM Tris, 150 mM NaCl , 0.20% DM (N-dodecyl β-D-maltoside), pH 8.0 
to 40 mM OG , 200 mM ammonium acetate, pH 8.0 using 100 kDa Amicon Ultra-0.5 centrifugal 
filter units (MilliporeSigma, Burlington, MA). Detergent screening and lipid binding studies were 
performed following established protocols,95 where the protein:lipid molar ratio was optimized for 
each lipid to be between 1:1 and 1:3, using an incubation period of 10 minutes per binding 
experiment. Protoporphyrin IX (PPIX) was dissolved in ammonium acetate buffer and added to 
TSPO in a light-free environment at an optimized protein:ligand ratio of 1:10. An endogenous 
ligand was noted to be present in some samples provided, and from these samples, replicates of 
the endogenous ligand (UNK) binding were generated without further preparation. 
 
2.2.2 CIU Experiments 
All CIU data was collected using a Synapt G2 HDMS IM-Q-ToF mass spectrometer 
(Waters, Milford, MA), with a direct infusion nESI source set to positive ion mode. Our instrument 
settings were tuned to generate intact protein ions while completely dissociating detergent adducts 
prior to the IM separator, including appropriately tuned settings for the source temperature (40° 
C), helium cell gas flow (100 mL/min), and the sampling cone (120 V). Trapping cell wave 
velocity and height were 116 m/s and 0.1 V. IMS wave velocity and height were 700 m/s and 32.5 
V.   Transfer cell wave velocity and height were 300 m/s and 10 V, with an accelerating potential 
of 70 V used to dissociate empty micelles. Collision cross section analysis was performed by 
established methods with the protein standards concavalin A, avidin, and β-lactoglobulin. 
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Theoretical collision cross sections of dimeric TSPO were calculatedusing IMPACT.99,130,131 All 
CIU analyses were performed by increasing the trap collision voltage in a stepwise manner 50 – 
140 V in 5 V increments. CIU data from the 9+ charge state of the TSPO dimer was extracted into 
a text-based format using TWIMExtract132, then processed and analyzed using CIUSuite 2.133 Data 
processing included two rounds of 2D Savitzky-Golay smoothing with a window of five bins and 
interpolation of the collision voltage axis by a factor of four.  
Gaussian de-noising and the subsequent classification of Gaussian processed CIU data was 
performed using a modified version of the classification module of CIUSuite 2, which we term 
CIUSuite 2.1, in conjunction with manual feature selection. Information regarding the algorithms 
that underpin CIUSuite 2.1 software is available elsewhere.134 Briefly, we modified the standard 
classification algorithm within CIUSuite by both standardizing and normalizing input CIU data as 
well as updating our approach to Gaussian fitting of IM ATDs. Our data normalization procedure 
is designed so that the most intense signals across different classes receive equal weight within 
resulting classifiers. We then standardize this data to a normal distribution possessing both a zero 
mean and unit variance.135 This approach prevents bias in the support vector machine (SVM) 
approach that we utilize to generate downstream classifiers and dramatically improves the 
robustness of the classifiers produced. In CIUSuite 2.1, the normalization and standardization steps 
described above have  been implemented for both raw CIU data and the Gaussian features that 
result from our de-noising procedures.133 For Gaussian data, fitted peak centroids, widths, and 
amplitudes were standardized separately at each collision voltage. If multiple peaks were present 
at a given collision voltage, their attributes were averaged for standardization.  The Gaussian fitting 
module of CIUSuite 2 was also updated as part of this work to utilize the optimized fitting results 
from the analyses of previous collision voltages as the initial guesses for the next collision voltage 
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data processed. Since CIU features are typically stable over several collision voltage steps, our 
CIUSuite 2.1 approach results in higher quality initial guesses in all cases, except for those IM 
datasets where new features first appear.  In general, this new Gaussian fitting approach results in 
more consistent and higher quality fits in the noisy membrane protein CIU datasets presented here. 
 
2.2.3 High Resolution MS Lipid Extraction Experiments 
30 μL of 1:2 chloroform:methanol solution was added to 2.5 μ L of 3.3 mM TSPO in 50 
mM Tris, 150 mM NaCl , 0.20% DM, pH 8.0. This solution was then vortexed and allowed to 
incubate for 10 minutes on ice. The resulting solution was dried under a stream of nitrogen gas 
and resuspended in 40 μL1:1 isopropanol:methanol,  sonicated for 30 minutes, and then directly 
infused into a nESI source of an Orbitrap Fusion Lumos Tribrid MS (Thermo Scientific 
Incorporated, Waltham, MA). MS spectra were collected in positive and negative mode, with mass 
selection and fragmentation performed for any peak of interest at HCD energy values between 0 
and 40. MS/MS data was analyzed using LipidMaps.89 
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2.3 Results and Discussion 
 
2.3.1 Analyzing CIU Data for TSPO:Ligand Complexes 
Previous reports have demonstrated the capabilities of CIU to capture stability shifts within 
membrane proteins upon ligand 
binding.122,123,136 However, generating 
robust, quantitative descriptions of 
membrane protein complexes using CIU 
remains a significant challenge, prompting 
the creation of custom CIU data analysis 
software.133,136 In this report, we present a 
new workflow for the automated quantitive 
analysis of membrane protein CIU data, 
which we utilize to extract stability values 
for a range of TSPO:ligand complexes, 
wherein we first detect complex ions using 
native MS, then perform CIU and assign 
each feature observed according to their 
voltage ranges and centroid IM drift times,   
allowing us to fit sigmoid functions to the 
transitions between the CIU features 
Figure 2-1. CIU analysis workflow for membrane protein complexes. 
A,B. Representative MS data for dimer TSPO:ligand complexes, 
where triangles denote TSPO monomers and circles represent PI 
(purple) and PG (green). C,D,E. CIU fingerprints of specific 
protein:ligand complex stoichiometries are analyzed through 
automated feature detection (shaded boxes) and CIU50 transition 
fitting (sigmoid traces). Here, 9+ dimer TSPO (MS not shown) and 
TSPO:ligand complexes are analyzed. F. CIU50 values are extracted 
across replicates, N = 3, in order to quantify complex stability and 
assess error, in this case clearly indicating the stabilization of TSPO 
upon binding both PI and PG lipids as opposed to when no lipid is 
present.    
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observed, and lastly extract the inflection points for each sigmoid fit, which we term the CIU50 
value. 
Two example MS datasets for TSPO:ligand complexes are shown in Figure 2-1, both 
acquired under activating conditions so as to dissociate the majority of interfering surfactant 
clusters and simplify MS interpretation. While both monomer and dimer states of the protein are 
observed over multiple charge states, the data shown in subsequent panels focuses on 9+ TSPO 
dimer signals. CIU experiments involve the stepwise increase of the field strength associated with 
the injection of ions into the trapping region preceding IM separation. Thus, ions accumulate 
excess kinetic energy, which is subsequently converted to internal modes via collisions with Ar 
gas, leading directly to protein ion unfolding. Plots of IM drift time versus the voltage are used to 
define the ion kinetic energies used to initiate CIU (CIU Fingerprints). These serve to track the 
structural transitions undergone by the ions as a function of their internal energies (Figure 2-1C). 
CIU fingerprints typically display multiple features related to protein ion unfolding, and we use 
CIUSuite2.1 software to detect and define these structural states in terms of their centroid drift 
times, and the range of collision voltages over which they appear. We then fit the transitions 
between the CIU features observed and extract the inflection points, or CIU50 values, for these 
fits from the data collected (Figure 2-1C-E). The example data shown in Figure 2-1 indicates that 
the transition between the most compact CIU feature and its nearest neighbor occurs at higher 
collision voltage values when PG or PI lipids are bound to the TSPO ions studied here (Figure 2-
1D, E).  In order to display and compare CIU stability data, we typically project bar charts that 
track each CIU50 recorded for the initial unfolding transition, although the CIU50 values for 
higher-energy transitions can also be readily compared in this fashion if the intensity of the highest 
energy feature reaches 50% of the maximum signal.   
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2.3.2 Data Processing Reduces Micellar Chemical Noise 
Previous reports have studied the role 
of detergent in preserving native-like 
conformations for gas-phase membrane 
proteins ions,95,137 indicating that detergent 
choice can dramatically impact IM-MS data 
quality and ion stability 
measurements.54,122,138 Data quality can also 
be impacted by surfactant-related chemical 
noise, where stable surfactant cluster ions can 
produce high intensity signals and excess 
detergent adduction can obfuscate protein 
data. Although the impact of surfactant-
related noise on the native MS analyses of 
membrane proteins can be observed in multiple 
previous reports,40,78,119,138 we have found such 
noise  to present a particular challenge for the 
IM-MS analysis of smaller membrane protein 
complexes, where significant overlap between 
micelle cluster ion signals and protein signals can exist. TSPO dimers, at 36 kDa, are an example 
of one such small membrane protein complex, where CIU analysis is dramatically complicated by 
chemical noise arising from OG detergent ions, which we have observed to be an optimal detergent 
Figure 2-2. A Gaussian noise filter for membrane protein CIU 
Data. A. IM-MS data for TSPO-ligand complexes where 
surfactant micelle-related noise overlaps with the signals for the 
9+ charge state of TSPO (boxed). B. Resulting CIU fingerprints 
recorded for the noise-contaminated 9+ TSPO signal. C, D. 
Gaussian fitting of interpolated TSPO IM drift time data 
recorded at a single collision voltage indicates that surfactant 
noise typically exhibits broader peak widths than TSPO signals, 
allowing informative protein signals (blue) to be sorted from 
noise (red) across all collision voltages scanned to create the 
complete CIU fingerprint. E. Performing feature detection on 
the Gaussian fitted peaks in panel D allows for the robust 
identification of three features within the resulting CIU 
fingerprint (see Figure S3 for more detail). F. Reconstruction of 
the features detected from the Gaussian fits gives a de-noised 
fingerprint. 
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choice for native MS of TSPO (Figure I-2).  For the TSPO data discussed in this report, we have 
developed a CIUSuite 2.1 approach that automatically detects and removes surfactant noise from 
CIU data using a combination of data interpolation and Gaussian filtering.  
Figure 2-2A displays a typical TSPO IM-MS dataset in the presence of OG detergent, 
where we observe signals identified as TSPO monomer and dimer over a range of charge states 
indicative of native like structures (5-12+). We chose to evaluate dimeric TSPO as it has been 
identified as the biologically active form.129 Furthermore, our native IM-MS data reveals evidence 
of ligand binding exclusively within dimeric TSPO. We focused our analysis on signals assigned 
to the 9+ charge state of the TSPO dimer based on their signal intensities relative to other dimer 
ion signals and their lack of m/z overlap with TSPO monomer signals. Additionally, the collision 
cross section recorded for 9+ TSPO, 2751 Å2, is in good agreement with theoretical estimates 
based on the available X-ray structure, 2741 Å2, indicating native-like folding for ions under these 
conditions (PDB 4UC1).14 A broad set of signals associated with OG surfactants and clusters is 
observed to overlap significantly with the TSPO 9+ peak (Figure 2-2A), producing CIU 
fingerprints contaminated with micellar noise, which increases in intensity relative to protein 
signals detected at higher collision voltages (Figure 2-2B).  
Automated Gaussian fitting applied to interpolated IM data acquired for 9+ TSPO dimer 
ions detects two main classes of ions readily differentiated based on their IM peak widths and 
intensities (Figure 2-2C), with broadened, low-intensity features belonging primarily to surfactant 
noise. We utilized this difference to identify the noise signals detected across all collision voltages 
scanned during the CIU experiment, developing a scoring algorithm based on peak width and 
intensity to do so (Figure 2-2D, I-3). While the signals assigned as noise appear at a variety of drift 
times, the most intense, and thus problematic, noise signals are those that occupy drift times similar 
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to those observed for protein ions. In the data shown in Figure 2-2, OG-related cluster ion noise 
signals appear at IM drift times ranging from 13.0 -15.5 ms across all collision voltages probed 
during CIU. In addition, we observe that the positioning of OG cluster ions in drift time-m/z space 
changes as a function of the collision voltage setting used to acquire CIU data, further complicating 
data analysis. Despite the challenge presented by this complex noise distribution, following our 
Gaussian de-noising procedure, we are able to accurately detect and quantify three TSPO CIU 
features free of interfering noise (Figure 2-2E, Figure I-4). These features can be used to 
reconstruct de-noised fingerprints from the Gaussian fits used during the de-noising process 
(Figure 2-2F), which can be used for CIU50 and classification analysis, in a manner impossible to 
achieve using the original CIU data alone.133  
 
2.3.3 Ligand Binding Generally Stabilizes TSPO 
Both lipids and protoporphyrins have known binding sites on the surface of the TSPO 
dimer, but little is known regarding the biophysical consequences of TSPO ligand binding. Figure 
2-3A indicates the locations for these binding sites which are based on a combination of crystal 
structures and computational modeling. Specifically, protoporphyrins occupy a discrete pocket 
between transmembrane helicies I and II and underneath loop 1, while phospholipids likely attach 
to both the hydrophobic dimer interface as well as a series large, hydrophobic grooves in the 
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membrane embedded region of the 
protein.129 Using native IM-MS we were 
able to evaluate nine TSPO ligands, 
including a diverse set of eight lipids and 
PPIX, observing a wide range of binding 
stoichiometries to TSPO dimers for each 
ligand tested (Figure 2-3, S4). All TSPO 
complexes studied here, except PC 
complexes, exhibited the same number of 
CIU features when compared to the unbound 
dimer, and resulted in various degrees of 
stabilization upon complex formation (Figure 
II-6). Our CIUSuite2.1 workflow was used to 
obtain de-noised CIU50 values for each 
complex observed.  
Figure 2-3 displays CIU50 values associated with the first unfolding transition observed, 
collected in triplicate for PPIX, six lipids (CDL, PA, PE, PI, PS, PG), and a previously unidentified 
endogenous ligand, labeled UNK. All of these ligands exhibited binding stoichiometries with 
dimeric TSPO ranging from 1:2-1:5. In order to compare CIU50 values across all complexes 
measured, Figure 2-3 plots CIU50 values that are a product of subtracting the equivalent unbound 
TSPO CIU50 value. This net CIU stabilization measurement reveals that PPIX binding stabilizes 
gas-phase TSPO to a greater extent than any protein-lipid complex detected and discrete lipid 
bound states appear to differentially stabilize the TSPO dimer. As noted above, TSPO-PC 
Figure 2-3. Net CIU stabilities of TSPO:ligand complexes. After 
incubation with a selected ligand, CIU50 values for 9+ TSPO dimer 
ions were quantified, N = 3, in a range of liganded states (key, 
bottom). The CIU50 of unbound TSPO (no lipid present) was 
subtracted from the CIU50 values extracted for TSPO:ligand 
complexes to generate a measurement of net CIU stability. Among 
lipids, subsequent binding events tend to increase TSPO stability, 
with some lipids acting to stabilize the complex to a greater extent 
than others. The PPIX binding site identified from X-ray  structures 
occupies a separate site from that identified for lipids (inset PDB 
4UC1),46 and TSPO:PPIX complexes exhibit enhanced stabilities 
when compared to the lipids screened here. An unidentified 
endogenous ligand (UNK) exhibits CIU stabilities with the greatest 
similarity to the majority of lipids analyzed in this report. 
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complexes provide a notable exception to this trend, in that lipid binding appears to destabilize the 
complex and alter the observed CIU pathway significantly (Figure I-6).  
The presence of TSPO-UNK complexes allows us to investigate the ability of CIU to 
classify an unknown membrane protein ligand, in this case, extracted endogenously from 
expressed TSPO samples.  A cursory analysis of the CIU data shown in Figure 2-3 indicates 
stability values for UNK complexes similar to most of the lipids screened in our experiments, 
excluding the lipids PS and CDL. Although we are unable to measure the mass of UNK in native 
MS data with high accuracy (740 ± 20 Da), such MS data supports the conclusion that the unknown 
ligand is likely not related to PPIX. Taking the 1:1 and 1:2 TSPO dimer:lipid complex CIU stability 
values observed as a guide, UNK CIU50 values are within error of those recorded for equivalent 
TSPO complexes containing both PG and PA.  As an MS/MS analysis of UNK could not be 
achieved due to the presence of significant surfactant-related chemical noise, we performed lipid 
extraction experiments aimed at identifying all endogenous lipids co-purified with TSPO samples. 
These experiments revealed a range of PG isoforms as the principle endogenous lipids present 
within these TSPO samples (Figure I-7). 
 
2.3.4 CIU Classification of Ligand Binding Location 
 As depicted in Figure 2-3, prior research has determined that TSPO possesses multiple 
binding surfaces for ligand attachment, including separate sites for drug and cholesterol 
attachment, not depicted.128 TSPO shares this quality with a plurality of membrane protein drug 
targets, and rapidly confirming binding location on a target protein surface often represents a 
significant challenge associated with the discovery of new therapeutics.73,139,140 As such, we 
investigated the ability of CIU to provide such information. We began by utilizing de-noised and 
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interpolated CIU fingerprints acquired for 1:1 
TSPO dimer:ligand complexes as a training 
dataset which can be sorted into two classes 
based on proposed binding location: PPIX and 
lipid-associated complexes. Using CIUSuite 
2.1, we built a classification scheme, where 
each voltage was evaluated for its ability to 
differentiate the two training classes, 
generating a score for each test (Figure 2-4A). 
By considering both the absolute value and 
error of the score generated for each voltage, 
the region shown in the gray box in Figure 2-
4A was automatically selected for a “leave one 
out” cross-validation step (Figure 2-4A,  inset) 
which serves to evaluate the robustness of an 
identified classifier through evaluation with 
data not included in the training set.133 Our 
analysis indicated that when the voltages 
ranging from 116.25 V to 125 V are used, the 
maximum classification accuracy of 0.99 is 
obtained, as measured by the area under the 
corresponding receiver operating characteristic 
curve (AUC-ROC).  
Figure 2-4. CIU based classification of TSPO ligands. A. We 
begin by scoring each voltage for its ability to differentiate all 
lipids from PPIX, N=3. Voltages shown within the gray box 
were those selected for a ‘leave one out’ cross-validation test, 
shown in the inset plot, where we tracked accuracy achieved 
with the training data (blue),non-training data (green), and the 
area under the ROC curve (red) as a function of the number of 
voltages included in the classification scheme. Based on these 
tests, two voltages (*) were selected for the final classification. 
B. A plot of linear discriminant space resulting from the 
classification structure described in A, illustrating clear 
separation of the CIU responses related to lipids from those 
recorded from PPIX. C. A bar chart tracking the probability of 
our class assignments for additional replicates that were not part 
of the dataset used to build the classification engine in A, where 
error bars shown reflect the assigned probability from each 
voltage. Three CIU replicates recorded for TSPO-UNK 
complexes provide high probability lipid assignments. 
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These eight voltages are used to build a CIU classification scheme and the results of the 
linear discriminant (LD) analysis are plotted on the resulting LD axis,  where we observe clear 
separation between PPIX and lipid CIU signatures (Figure 2-4B). To further test the strength of 
our classification scheme, additional replicates not included in our original training set were input 
into our classification structure as “unknowns”. We analyzed the results of this mock unknown 
classification experiment by assessing the probability associated with the ligand class assignment 
indicated by CIUSuite 2.1 (Figure 2-4C). All of our mock unknowns analyzed in this way classify 
correctly.  In addition, data for TSPO-UNK complexes resulted in high probability lipid 
classifications, as predicted by the analysis of our CIU50 values displayed in Figure 2-3. The data 
shown in Figure 2-4 represents the first time CIU data has been used to classify ligands to 
previously identified disparate binding locations within a membrane protein complex, and the first 
instance of using CIU to identify an unknown ligand class with a quantified level of confidence.  
 
2.3.5 CIU Differentiates TSPO:Lipid Complexes Based on Chain Saturation 
Lipids can play functional roles upon binding to membrane proteins, engendering the 
possibility of specific binding pockets, where the detailed structure of the intended binder may 
affect its ability to interact with the protein.40,124,139 The structure of lipids can include variations 
in head group, chain length, and chain saturation, all of which can exert biological effects.141 
Therefore, we proceeded to evaluate the ability of CIU data to classify TSPO:lipid complexes 
according to their specific chemical structures, finding the greatest correlations in our CIU data to 
lipid chain saturation levels.   
As lipids are often distinguished by their head group, we began by grouping the lipids we 
analyzed in our study based on their overall physiological charge. However, all attempts to build 
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a classification scheme based on lipid 
physiological charge resulted in poor cross 
validation testing and incorrect assignment of 
some lipids (Figure I-8). Noting the 
similarities between the CIU data collected for 
TSPO complexes containing PE and PA 
(Figure I-8 C), and that TSPO possesses large 
hydrophobic lipid binding grooves,14 we next 
focused on lipid tail attributes in order to 
classify TSPO:lipid complex CIU data.  To 
construct our classification scheme, we sorted 
our 1:1 TSPO dimer:lipid CIU data into 
groups based on lipid tail saturation levels, 
including saturated (PG, PI), one double bond 
containing (PS), and two double bond 
containing (PA, PE) lipids. Data for CDL and PC 
complexes were left out of classification efforts, 
as when compared with the majority of the lipids 
studied here, they possessed either a different 
number of chains or exhibited evidence of a 
significantly altered CIU pathway, respectively. 
Our general procedure for constructing our three-
way lipid saturation-based classification scheme 
Figure 2-5. CIU based classification of lipid chain saturation 
in TSPO complexes. A. Each voltage was scored for its ability 
to differentiate the following three classes: saturated lipids 
(PG, PI), lipids with one double bond (PS) and lipids with two 
double bonds (PA, PE), N = 3 for each ligand. Voltages in the 
gray box were selected for cross-validation runs, where the 
inset plot is formatted identically to the one shown in Figure 
4. Based on this analysis, one voltage (*) was found to provide 
the most accurate classification scheme. B. A three-way CIU 
classification depicted as decision regions on linear 
discriminant axes, illustrating the separation of all three 
classes. C. A bar chart plotting the probability of correct 
assignment for lipids replicates not included in the training 
data evaluated in A, where the true saturation of each lipid is 
shown using a color code as indicated. Each lipid is correctly 
assigned, and three replicates of UNK, suspected to have a PG 
head group, show the most likely assignment to be the 
saturated isoform, followed by isoforms containing a single 
double bond 
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was similar to the approach described above for building our two-way lipid/PPIX classification 
scheme (Figure 2-4). A notable difference between our lipid saturation level based classification 
scheme and our two-way lipid/PPIX classification structure is that the optimally differentiating 
region of our CIU data identified is at lower voltage values than those selected as optimal for 
lipid/PPIX discrimination. Our cross-validation testing demonstrated that using CIU data acquired 
at one voltage, 88.75 V, provides a classification scheme of greatest accuracy, resulting in a 0.72 
AUC-ROC (Figure 2-5A). Although the accuracies measured in our cross-validation runs for this 
scheme are lower than those generated in Figure 2-4, this is expected when evaluating a three-way 
classification, where assignments are not binary (Figure 2-5B).  
In our three-way classification scheme, the assignment probabilities for each CIU dataset 
are shown as a stacked bar graph in Figure 2-5C for nine datasets not included in our training data. 
While mock unknowns are assigned to chain saturation classes with a range of probabilities, the 
lowest of which is associated with a PA dataset shown, all CIU datasets are correctly assigned to 
the appropriate chain saturation class.  This includes CIU data for PC, a sample for which no 
replicates were included in the training dataset. The CIU replicates for UNK can be assigned with 
moderate confidence as a saturated lipid (with probabilities of 74%, 72% and 62% for the three 
datasets acquired), where the second most likely lipid class assignment includes one degree of 
chain unsaturation (Figure 2-5C). The ambiguity of these assignments can be rationalized using 
HRMS lipid extraction data (Figure I-7). While these data identified saturated PG (16:0) as the 
dominant endogenous lipid form present within these TSPO samples, other PG isoforms, including 
many with one degree of unsaturation, were also identified. While the HRMS data cannot assign 
which of these lipids is bound within the TSPO:UNK complexes detected in our experiments, it is 
possible that UNK is comprised of a mixture of PG isoforms, containing both saturated chains and 
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those containing one double bond. Our proposed assignment for UNK is also in agreement with 
X-ray data analysis reported for a TSPO mutant.14 Overall, the data shown in Figure 2-5 represents 
the first example of using CIU data to classify protein complexes in terms of the chemical 
structures of the bound ligands, and provides a foundation for future membrane protein complex 
analyses where CIU data is leveraged to aid in the identification of unknown endogenous ligands. 
 
2.4 Conclusions 
CIU is a promising technique for studying ligand binding within membrane proteins, 
despite challenges related to chemical noise. We have designed data analysis workflows aimed 
specifically at addressing these noise related challenges, and have applied these workflows to gain 
new insight into the ligand binding behavior of TSPO.  Complexes containing ligands known to 
bind at two separate sites were detected as possessing differential stabilities using CIU, where 
PPIX binding provides a greater degree of gas-phase stabilization for TSPO than any of the lipids 
assessed here.  While our data alone does not enable us to rule out the presence of rearranged 
TSPO structures under our conditions, such information suggests that a stronger intermolecular 
interactions exist within TSPO:PPIX complexes than when compared to equivalent lipid binding 
events, and furthermore indicates that TSPO ligand complexes retain a strong memory of their 
native-state structures in the gas-phase.  
Furthermore, we constructed two CIU-based classification schemes for TSPO and 
observed the successful differentiation of lipid binders from PPIX, as well as sub-classes of lipids 
based on their levels of chain saturation. These include iso-mass lipids (e.g, POPC and POPS, both 
having an average mass of 760 Da), which we are able to confidently differente based on CIU 
classifiers. The construction of our classification schemes also revealed that level of lipid chain 
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saturation, rather than charge, dictates the gas-phase unfolding of TSPO.  This observation is 
congruent with the large, hydrophobic lipid binding grooves on the surface of TSPO observed in 
X-ray structures for the complex.31 By combining CIU data at the level of intact protein complexes 
with HRMS data collected on extracted lipids co-isolated with TSPO, we propose the identity of 
a detected unknown endogenous ligand to be a heterogeneous population of PG isoforms 
containing various states of chain saturation. Such a determination would be challenging, if not 
impossible, to achieve with contemporary MS/MS approaches. Clearly, rapid advancements in 
CIU technology are acting to position this approach within the broader structural MS field, as a 
uniquely flexible biophysical tool, capable of assessing the composition, stability, and structure of 
membrane protein assemblies within complex mixtures. 
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Chapter 3 Ion Mobility -  Mass Spectrometry Reveals the Role of Peripheral Myelin 
Protein Dimers in Peripheral Neuropathy 
3.1 Introduction 
The misfolding of membrane proteins is implicated in the mechanisms of multiple 
debilitating diseases, including cystic fibrosis and retinitis pigmentosa.142–145 Often, specific 
sequence membrane protein mutations  are associated with disease states, with variant forms 
exhibiting altered stability and cellular trafficking.146 Unfortunately, due to the challenges 
associated with preparing and handling pure, highly concentrated membrane protein samples, 
detailed structural information on such targets is often lacking, especially for disease mutant forms. 
Further, as some membrane proteins associated with misfolding diseases have hundreds of 
mutations of interest,144 there is a clear need for high-throughput methods to assess dynamic 
structural changes in membrane protein folding. 
Peripheral myelin protein 22 (PMP22) is such a membrane protein, for which misfolding 
and trafficking of mutant variants have been implicated in disease.20 PMP22 is a tetra-span integral 
membrane glycoprotein predominately expressed in Schwann cells which are the principal glial 
cells of the peripheral nervous system (PNS), where they produce myelin.147–149 In addition to 
accounting for ~5% of the protein found in the myelin sheath surrounding PNS nerve axons, 
PMP22 is thought to regulate intracellular Ca2+ levels,150 apoptosis,151 linking of actin-
cytoskeleton with lipid rafts,152 epithelial intercellular junctions formation,153 myelin formation,154 
lipid metabolism and cholesterol trafficking.155 Dysregulation and misfolding of PMP22 has been 
identified as a key factor in multiple neurodegenerative disorders, such as Charcot Marie Tooth 
disease types 1A and E, as well as Dejerine-Sottas Syndrome17,19,20,156. Like a number of other 
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disease-linked membrane proteins,157 the trafficking of PMP22 is known to be inefficient, with 
only 20% of the wild-type (WT) protein reaching its final membrane destination in Schwann 
cells.158 Previously, it has been shown through  a range of biophysical analyses that disease 
associated PMP22 mutations lower protein stability and further reduce trafficking, however the 
mechanism by which these mutant forms of PMP22 cause disease is still not well understood.20 
Additionally, a high-resolution structure of PMP22 has not yet been published.  
Native mass spectrometry has recently been demonstrated to overcome sample purity and 
concentration barriers to reveal critical details of membrane protein structure and function.54,95,159 
Through the use of nano-electrospray (nESI), intact membrane proteins are ionized within 
detergent micelles or other membrane mimetics,119,138,160,161 which can then be removed from the 
membrane protein ions within the instrument. This method has been used to elucidate oligomeric 
information,40,116,162 complex organization,52,163 and lipid interactions 93,96,118 of diverse membrane 
proteins. The addition of ion mobility separations to mass spectrometry (IM-MS), provides data 
on the orientationally-averaged size of analytes,99 and enables collision induced unfolding (CIU) 
experiments.100 In CIU, the energies experienced by gas phase protein ions are ramped in a step 
wise fashion causing unfolding. These dynamic measurements have been shown to be sensitive to 
ligand binding,164,165 glycosylation,166,167 and disulfide bonding166 in soluble proteins, as well as 
selective lipid and small molecule binding in membrane proteins.94,102,106,168 While CIU can clearly 
capture subtle structural changes in proteins, its performance in discerning membrane protein 
stability as a function of protein mutation has yet to be described.  
Here, we demonstrate the ability of native mass spectrometry and CIU to detect key 
differences in the stability and complex formation of PMP22 variants, leading to new insights into 
the mechanism of PMP22 dysregulation in disease. We quantify the propensity of PMP22 to 
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dimerize across WT and seven disease-associated point mutations. We find that mutations 
associated with severe disease states form significantly more dimer than WT. Through CIU, we 
quantify the stability of gas phase monomeric and dimeric PMP variants and find that PMP variants 
bearing  mutations connected to severe neuropathy exhibit the lowest relative monomer 
conformational stability. Interestingly, we observe that all dimers of mutant PMP22 forms are 
more stable than WT PMP22 dimeric complexes. We continue by comparing our results to 
previously published biophysical datasets and find that our monomeric PMP22 gas phase stability 
values correlate well with cellular trafficking data.20 Lastly, we probe the effects of solubilization 
agents on PMP22 by characterizing its dimerization within sphingomyelin and cholesterol rich 
(SCOR) bicelles. We find that dimeric PMP22 complexes persist within SCOR bicelles and that 
the differences we observed in dimer abundance between WT and severe mutant protein forms are 
intensified. We conclude by proposing a new mechanism of PMP22 dysregulation in severe 
neurodegenerative diseases by which PMP22 monomers are destabilized and more prone to form 
poorly trafficked dimeric complexes than WT PMP22.  
 
 
3.2 Methods 
 
3.2.1 Membrane Protein Sample Preparation 
PMP22 WT and mutant variants (S22F, A67T, T118M, G93R, L16P, H12Q, and G150D) 
were expressed in E. Coli. using protocols adapted from Schlebach et al.169 Octaethylene Glycol 
Monododecyl Ether (C12E8) and n-Dodecyl-β-D-Melibioside (DDMB) were purchased from 
Anatrace. Ammonium acetate was purchased from Sigma Aldrich (St. Louis, MO). Detailed 
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information on the purification of PMP22, preparation of sphingolipid and cholesterol rich (SCOR) 
bicelles, and incorporation of PMP22 into SCOR bicelles can be found in the supporting 
information.  For detergent-based native MS experiments, 50 µM PMP22 was buffer and 
detergent-exchanged simultaneously from 50 mM Tris buffer pH 8.0, 0.15% β -n-decyl maltoside 
(DM), 15 mM imidazole and 1 mM TCEP  buffer and 0.1% β -n-dodecylmaltoside (DDM) to 
0.02% C12E8 (~4 x CMC), 200 mM ammonium acetate pH 8.0 using 10 kDa Amicon Ultra-0.5 
centrifugal filter units (MilliporeSigma, Burlington, MA). Detergent screening was performed 
following established protocols.95 For SCOR bicelles native MS experiments, 40 µM PMP22 in 
10 mM acetate buffer (pH 5.0) containing 100 mM NaCl, 0.2 % SCOR bicelles (q = 0.33), 1 mM 
EDTA, 5 mM TCEP, and 0.3 mM DDMB was exchanged into 200 mM ammonium acetate pH 8.0 
using 10 kDa Amicon Ultra-0.5 centrifugal filter units. 
 
3.2.2 Native IM-MS 
 All IM-MS data was collected using a Synapt G2 HDMS IM-Q-ToF mass spectrometer 
(Waters, Milford, MA), with a direct infusion nESI source set to positive ion mode. Instrument 
settings were tuned to dissociate solubilization agents with minimal perturbation to protein 
structure prior to the IM separator, including appropriately tuned settings for the source 
temperature (30° C), source gas flow (50 mL/min), and the sampling cone (120 V). Trapping cell 
wave velocity and height were 116 m/s and 0.1 V. IMS wave velocity and height were 250 m/s 
and 15 V.   Transfer cell wave velocity and height were 300 m/s and 10 V, with an accelerating 
potential of 70 V used to dissociate empty micelles and bicelles. Collision cross section analysis 
was performed by using IMSCal-19v4, a program written in C. Theoretical collision cross sections 
of monomeric PMP were calculated using a previously published homology model170 and 
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IMPACT.99,130,131 Percent dimer calculations were performed at trap collision voltages of 80V to 
minimize the impact of surfactant related noise. Arrival times distributions of charge states that 
were known to be uniquely monomer or dimer, as indicated in Figure 3-1A and Figure II-3, were 
extracted using to a text-based format using TWIMExtract.132 For data where excess detergent and 
lipid noise was present at low arrival times, the extraction window was set to begin at the drift 
times indicated in Figure II-8. To calculate the percent dimer, the sum of the extracted dimers is 
divided by the monomer sum added to the dimer sum.  All CIU analyses were performed in 
triplicate by increasing the trap collision voltage in a stepwise manner from 5 – 150 V in 5 V 
increments. CIU data from the 9+ and 13+ charge states of monomeric and dimeric PMP22, 
respectively, were extracted using TWIMExtract132, then processed and analyzed using CIUSuite 
2.133 Data processing included three rounds of 2D Savitzky-Golay smoothing with a window of 
five bins and interpolation of the collision voltage axis by a factor of four.  
 
3.2.3 High Resolution MS Lipid Extraction Experiments 
PMP22 S22F was prepared as described above for IM-MS experiments. HRMS 
experiments were performed on an Orbitrap Fusion Lumos Tribid MS (ThermoFisher, San Jose, 
CA). Instrument settings were optimized to dissociate the detergent micelle to facilitate detection 
of the PMP22 signal. The in-source fragmentation voltages were enabled and set to 100 V. The 
transfer tube temperature was also increased to 325 degrees. The ions were subjected to higher-
energy C-Trap Dissociation (HCD) at an energy of 22.5% to further liberate the PMP22 from the 
detergent micelle. All HRMS spectra were collected at a resolution 120000 FWHM at 200 Th and 
with the rf frequency set to 30 %. 
  
  40 
3.3 Results and Discussion 
 
3.3.1 Quantifying Abundance of PMP22 Dimers 
The existence of PMP22 
homodimers formed by WT and mutant 
PMP22 variants,169,171 as well as 
aggregation-like higher order species,172–174 
has been inferred from low resolution mass 
separations and biophysical assays. 
Therefore, we endeavored to use native mass 
spectrometry, which enables the 
characterization of oligomeric state through 
detectable differences in the m/z of protein 
ions, to analyze PMP22 oligomeric species. 
While PMP22 has not previously been 
studied via native MS, we find that PMP22 
liberated from C12E8 detergent micelles 
reveals two distributions of protein related 
signals with charge states of 10+ to 6+ and 15+ 
to 11+, as shown in Figure 3-1A. The two 
distributions indicate that multiple protein 
oligomeric states are present, and the masses 
calculated from the charge state distributions, 
Figure 3-1. Native IM-MS of PMP22 reveals differences in 
dimeric abundances. A. Mass spectra of PMP22 liberated from 
detergent micelles produces populations of monomer and dimer 
protein at charge state ranges of 6-10+ and 11-15+, respectively. 
Charge states were identified as containing only monomer 
(green), only dimer (blue), or a mix of monomer and dimer 
(gray). B. Intensities for PMP22 signals identified as  monomer 
or dimer were used to calculate the percent dimer in wild-type 
(WT) PMP22, as well as seven mutant PMP22 variants, N = 3. 
Notably, L16P, H12Q, and G150D, mutants correlated with 
severe disease phenotypes, exhibit significantly more dimer 
(41.0 ± 0.4%, 37.3 ± 0.6%, 28.1 ± 1.5%) than WT (23.2 ± 0.3%). 
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19.4 kDa and 39.1 kDa, correspond well to those expected for monomeric and dimeric PMP22 
(Table S1). The data presented here is the first time a PMP22 homodimer has been confirmed and 
characterized. Notably, the calculated collision cross section (CCS) for monomeric PMP22 in 
these experiments was 1595 Å2, which agrees well with the theoretical cross section calculated for 
folded PMP22 based on a previously published homology model of 1535 Å2.170 The CCS 
agreement, as well as the range of charge states observed, indicate that PMP22 monomers retain 
compact conformations when subjected to IM-MS analysis. 
The observation of a PMP22 homodimer prompted us to quantify its relative abundance 
across a range of disease associated PMP22 mutants. As there is some overlap between the IM-
MS signals corresponding to PMP22 monomer and dimer, in order to calculate the abundance of 
dimer, we filtered all signals detected using both IM and MS data leaving only those signals that 
could be identified as uniquely resulting from monomer or dimer PMP22 (Figure 3-1A). For 
example, our measurements indicate a 23.2 ± 0.3% dimer population for WT PMP22. 
Of the 44 pathogenic missense mutations known to exist for PMP22, we chose seven 
mutations occurring throughout its sequence based on their prevalence, disease phenotype 
relationship, and previous biophysical assay behavior (Figure II-2). Two mutants, S22F and A67T, 
are associated with hereditary neuropathy with liability for pressure palsies (HNPP), which is 
considered a mild neuropathy.17,175 Previous assays have found that S22F and A67T have 
trafficking efficiencies and folding stabilities comparable to WT PMP22.20 Another set of mutants, 
T118M and G93R, are associated with Charcot-Marie-Tooth 1 disease (CMT1), a moderate form 
of neuropathy.156,176 These mutations were observed to cause a reduction in cellular trafficking and 
stability relative to WT,20 and recent computational modelling of T118M PMP22 indicate that the 
mutation causes changes to structural stability.177 Relative quantitation of the dimer states for these 
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four PMP22 mutations exhibit abundances within error of each other, but significantly lower than 
that of WT PMP22 (Figure 3-1B).  
The final three mutants analyzed in this work, L16P, H12Q, and G150D, are associated 
with Dejerine-Sottas Syndrome (DSS), a severe neuropathic condition. These mutations were 
previously found to cause a dramatic reduction in cellular trafficking for PMP22, as well as  
decreased stability.20,177–179 Strikingly, we observed that all three of these mutant PMP22 forms 
exhibited a significantly larger amount of dimer than WT PMP22 or mutations corresponding to 
mild or moderate disease phenotypes (Figure 3-1B). The severe disease mutations H12Q and L16P 
exhibited 41.0 ± 0.4%  and 37.3 ± 0.6% dimer, respectively, while G150D shows a more moderate 
increase in dimer relative to WT, at 28.1 ± 1.5%. As H12Q and L16P occur in the first 
transmembrane spanning helix and G150D in the fourth transmembrane spanning helix (Figure II-
2), these differences in dimeric abundance may indicate that the mutation site Q12 and P16 
residues are associated with the PMP22 homodimer interface.  
 
3.3.2 CIU Reveals Differential Stabilities of Monomeric PMP22 Mutants 
The folding and stability of PMP22 mutants have been linked to their mistrafficking, and 
role in neuropathies.145 However, as a high-resolution structure of PMP22 has not yet been 
determined, measurements related to the folding of PMP22 have largely been made from bulk 
solution,169 biochemical, biophysical and cellular assays,20 and molecular dynamic 
simulations.170,177 While chemical modification has been used to specifically study WT PMP22 
dimers,169 many reports  convolute the various oligomeric states of PMP22. The gas phase 
unfolding of membrane proteins has been previously reported to inform on the conformational 
dynamics and stability of protein structures,94,168 and it allows for independent analysis of discrete 
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protein forms that are separated in m/z. Advances in CIU analysis software have also enabled the 
automated identification of features, and the fitting of sigmoidal transitions between such 
identified features.133 We proceeded to use this approach to evaluate the role of mutations in the 
stability of monomeric and dimeric PMP22.  
 The feature observed at the lowest 
drift time and collision voltage represents the 
most folded and native-like conformational 
family observed for the PMP22 monomer in 
our experiments, while  features appearing at 
longer IM arrival times correspond to a more 
unfolded PMP22 conformations. Sigmoidal 
curves fit to the transitions between CIU 
features, allow us to compute inflection 
points, or CIU50 values, that we use to 
compare the relative stabilities of PMP22 
variants.133,168  
 Figure 3-2A displays averaged CIU 
fingerprints, N = 3, with detected features 
(left) and sigmoidal fits (right) for 9+ 
monomeric PMP22 WT, as well as example 
mutants from each disease severity 
phenotype. While a CIU50 of 19.8 ± 0.4V is 
observed for WT PMP22, variants of PMP22 
Figure 3-2. CIU data for monomeric PMP22. A. Analysis of 9+ 
monomer WT PMP22 and all mutant PMP22 forms tested identify 
two features between 5V and 45V. Fitting a sigmoid to these 
features allows for CIU50 determinations. B. CIU50 values 
recorded for monomeric WT and mutant PMP22, N = 3, ordered 
by the disease phenotype severity engendered by the indicated 
mutant. 
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possessing the A67T, G93R, and L16P mutations all exhibit a range of CIU50 values significantly 
lower than that observed for WT. These lower CIU50 values indicate that PMP22 mutants are 
destabilized in a manner correlated with the severity of the neuropathy they induce. A clear 
example of this trend is apparent upon comparing CIU data collected for WT PMP22 (teal) and 
L16P PMP22 (pink), where the feature appearing at longer drift times in the L16P PMP22 data 
begins at significantly decreased collision voltage values when compared to the analogues feature 
appearing in the WT fingerprint, resulting in an average CIU50 of 16.1 ± 0.3V for the mutant 
protein.  
 Destabilization is observed for all PMP22 mutants studied here, except for S22F, where 
each mutant protein monomer exhibits an average CIU50 value significantly below the lower 
bound of error defined for our WT CIU50 measurement, (Figures 3-2B and II-5). The observation 
that monomer S22F PMP22 exhibits a stability comparable to WT PMP22 is interesting in light of 
previously published data concluding that this variant may be trafficked more efficiently than WT 
and exhibits unique metal binding properties.20 We note that the most destabilized class of PMP22 
variants are those associated with severe neuropathy (pink). Specifically, H12Q and L16P PMP22 
exhibit CIU50 values of 16.1 ± 0.3V, and 15.4 ± 0.7V, which are both significantly less than the 
stability we record for the WTPMP22. This observation agrees well with previous data recorded 
for these mutatants;20,170,177 however, this study represents the first direct stability measurements 
of mutant PMP22 monomers 
 
3.3.3 Mutant PMP22 Dimeric Complexes Are More Stable Than WT 
Both While the mistrafficking of PMP22 is a common theme in its proposed roles in 
neuropathic disease,145,171,180 the underlying mechanism involved, as well as the fate of proteins 
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which do not get properly trafficked, are still active areas of research. Proposed as either a cause 
or a consequence of mistrafficking, PMP22 
oligomerization has been linked to the etiology 
and possible treatment modalities for its 
associated importance of PMP22 oligomers to 
its dysregulation we assessed the stability of 
PMP22 homodimers detected in our 
experiments as a function of protein mutation. 
To study the CIU of PMP22 dimers, we 
selected the 13+ charge state, as it appears 
across all datasets and cannot overlap with 
monomeric ions. Automated feature analysis 
detected two conformational populations 
between 5V and 60V for all WT and mutant 
PMP22 dimer fingerprints. Sigmoidal fits 
between these two states yielded reproducible 
CIU50 values (Figure 3-3A). We interpreted 
these data similarly to the monomeric 
fingerprints described in Figure 3-2, where 
CIU50 values were compared across dimeric 
fingerprints for all PMP22 variants (Figures 3-3B and II-5).  
In contrast to monomeric data, we find that all variant dimers exhibit enhanced stability 
relative to WT.  Specifically, we record WT PMP22 dimer CIU50 of 25.6 ± 0.4V, while all mutant 
Figure 3-3. CIU data for dimeric PMP22. A. Analysis of the 13+ 
WT PMP22 dimer and all mutant PMP22 forms exhibit two 
features between 5V and 60. B. CIU50 values for WT and mutant 
PMP22 dimers, N = 3, ordered by disease phenotype severity. 
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variants studied here exhibit significantly larger values, ranging from 29.3 ± 1.4V to 36.8V ± 3.0V. 
Note that equal levels of homodimer stabilization is observed for all mutant variants, despite the 
differences between  mutants in relative abundance of homodimeric complexes (Figure 3-1B). 
Additionally, the stability measurements reported by the CIU50s in Figure 3-3 reflect the unfolding 
of the intact dimeric complexes, not dissociation events. However, no clear differences between 
CIU50s of dimeric PMP22 mutants associated with different disease phenotypes is observed. 
Given the literature precedence for PMP22 oligomers,172–174 our findings clearly support the notion 
that destabilized mutant PMP22 monomers are also more apt to form stabilized dimeric states, and 
this equilibrium plays a role in disease state severity. This insight is further supported by the 
general correlations we observe between disease severity, monomeric stability, dimer stability, and 
the quantitative amounts of PMP22 dimers detected in our experiments.  
 
3.3.4 Gas Phase Stability Data Correlate with Cellular and in vivo Assays 
 To probe how our results fit with prior findings associated with PMP22 mutations, we 
performed a series of correlative analyses where we plotted our native MS and CIU data presented 
in Figures 3-1 and 3-2 against previously published cellular and in vivo data.20 For these analyses, 
we included prior data tracking cellular trafficking efficiencies, nerve conduction velocities 
(NCV), and Gibbs free energy of Zn(II) binding (ΔΔGapp,total), which informs directly on the 
solution phase folding of PMP22. 
 We first assessed how our monomer stability data and dimer abundance values correlated 
to patient NCVs, as such data presents the most direct link to disease phenotype. Previously, NCVs 
have been shown to correlate well with both trafficking efficiency (R2 = 0.88) and ΔΔGapp,total (R2 
= 0.64) in an analysis of a larger set of ten PMP22 mutants.20 While we find no significant 
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correlation between NCVs and the abundance 
of dimeric complexes measured here (Figure 
II-6B), we do observe a correlation between 
the CIU50 monomeric stability of PMP22 and 
patient NCVs (R2 = 0.57, Figure II-6A). The 
nature of this relationship is proportional, 
where a lower monomeric CIU50 value is 
associated with slower nerve conduction 
velocities. We next explored relationships 
between the ΔΔGapp,total and our measurements, but found no significant correlations for either the 
PMP22 monomeric stability values or our abundance measurements for PMP22 dimers (Figures 
II-6D,E).  We interpret this result as stemming from the foundational differences underpinning the 
two measurements analyzed in these separate studies. First, the prior data relies specifically on 
Zn(II) binding to PMP22, and Zn(II) was not present in our native IM-MS experiments. Secondly, 
in the CIU experiments we are extracting stability information from specific oligomeric species, 
where the solution phase experiments are likely sampling complex mixture of PMP22 oligomers.  
 We find that cellular trafficking efficiency data correlates strongly with our monomer 
CIU50 values (R2 = 0.80, Figure 3-4)  . The quadratic regression shown in Figure 3-4 exhibits a 
relationship wherein less stable PMP22 monomers are associated with reduced cellular trafficking. 
Additionally, we find that PMP22 trafficking efficiency is anti-correlated with the dimer 
abundance values recorded from our native IM-MS measurements (R2 = 0.66, Figure II-6F). 
Notably, the mutants associated with severe forms of neuropathy, H12Q, L16P and G150D, cluster 
at the extremes of these plots, all exhibiting low trafficking efficiencies, low monomeric stabilities, 
Figure 3-4. Correlation between monomer CIU50 stability values 
and PMP22 trafficking efficiencies, N = 3.20 CIU50 values are from 
the 9+ monomeric charge state of PMP22 and describe the relative 
stability of the protein forms. Mutations associated with different 
disease severities are color coded. A quadratic regression (y = 
0.3538x2 - 8.4629x + 47.218) fit is shown for the data, along with 
errors for each dataset, producing a correlation coefficient of 0.80, 
which shows a positive correlation between monomeric protein 
stability and trafficking efficiency 
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slow NCV values, and abundant dimers. The above correlations clearly indicate the importance of 
PMP22 dimers, an oligomeric state ultimately fed by the stability of the preceding monomers, in 
predicting PMP22-associated disease phenotypes.  
 
3.3.5 Encapsulation within SCOR Bicelles Engenders Mutant PMP22 Homodimer 
Formation 
Lipids are recognized as key regulators of membrane proteins through selective 
interactions or association with the membrane itself.40,181–183 Many biochemical processes are 
thought to be driven by partitioning of membrane proteins into nanodomains containing saturated 
lipids, sphingolipids, and cholesterol.184,185 The myelin membrane in which PMP22 natively 
resides is rich in cholesterol and sphingomyelin, and the protein is thought to play an important 
role in cholesterol homeostasis.155,186,187 Recently, a novel bicelle construct aiming to imitate the 
ordered membrane environment  encountered natively by PMP22 has been described.188 These 
sphingomyelin and cholesterol rich (SCOR) bicelles have been found to be compatible with a wide 
range of biophysical measurement techniques, including native IM-MS.188 To evaluate the effect 
of a more native-like lipid environment on the formation of PMP22 homodimers, we employed 
SCOR bicelles to prepare samples for native IM-MS analysis.  
In Figure 3-5A, an example plot of IM drift time versus m/z  for PMP22 L16P liberated 
from SCOR bicelles is shown, and we observe signals associated with monomer (green), dimer 
(blue), and overlapping PMP22 oligomeric states (gray). Additionally, noise signals associated 
with lipid and detergent clusters can be observed in the lower IM drift times and m/z values (not 
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shown). Due to this noise, the SCOR 
bicelle-related data shown in Figure 3-5C,E 
were background subtracted for 
visualization purposes, and prior to our 
quantitative analysis of the PMP22 dimers 
observed, data were de-noised (Figure II-8).  
MS data collected for these samples 
exhibited evidence of enhanced levels of 
adduction (Figure 3-5B-E), which likely 
stems for the sample preparation procedures 
associated with SCOR bicelles used in these 
experiments (also observed in Figure II-7). 
Figure 3-5F displays our quantitative 
analysis of PMP22 dimers for WT, L16P, 
and G150D variants liberated from micelles 
and SCOR bicelles. While minor 
differences exist in the amount of dimer 
observed for the mutants between our 
micelle and bicelle in our measurements, we 
detect significant differences in the relative 
abundance of WT dimers ejected from SCOR bicelles when compared with our micelle data, which 
produced values of 22.7 ± 0.3% PMP22 dimer in micelles and only 5.6 ± 0.6% dimer in SCOR 
bicelles. This data further demonstrates that the increased levels of dimer we detect are not an 
Figure 3-5. WT and L16P PMP22 liberated from SCOR bicelles. A. IM-MS 
of L16P liberated from SCOR bicelles reveals populations of monomer and 
dimer PMP22 as well as lipid and detergent related noise (low m/z noise not 
shown). Such noise was systematically excluded from all further analysis 
(Figure II-8). B-E. Mass spectra of WT PMP22 liberated from either detergent 
micelles or SCOR bicelles (as indicated), followed by similar data collected 
for L16P PMP22. Monomeric PMP22 (green) and dimeric PMP22 (blue) is 
present in each spectra, but in varying amounts. F. Measured percent dimer 
values from native IM-MS.  Significant differences in these values are 
observed between mutants and solubilization techniques 
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artifact associated with the location of the mutation studied, but rather a function overall structure 
and stability of the PMP22 variant. Overall, these observations demonstrate the importance of the 
native membrane and lipid environment on PMP22 dimer formation, and are further evidence that 
PMP22 homodimers complexes are strongly correlated with mutations that give rise to severe 
neuropathies. 
 
3.4 Conclusions 
The role of PMP22 in neuropathies is complex, with its folding, stability, trafficking, and 
aggregation all previously indicated as important predictive links to its role in 
disease.20,172,177,178,189 Native IM-MS and CIU have allowed us to identify PMP22 homodimers as 
a new candidate for inclusion among these factors. Our measurements enabled the stabilities of 
PMP22 monomers to be untangled from their associated oligomers, and they suggest that those 
mutations that engender the least stable monomers also produce the most stable dimers. These 
results indicate that those monomers that are least stable, and thus most likely to form dimers, are 
also those most likely to accumulate a significant dimeric population. The likelihood that these 
results bear relevance under native cellular environments is high, as our SCOR bicelle 
measurements reveal a more dramatic difference in dimer amounts in WT and disease-associated 
mutants.  Furthermore, if these observations are combined with our analyses that highlight 
correlations between our results and previous measurements of PMP22 trafficking efficiency, a 
mechanistic link can be formed between protein misfolding, dimer production, and a loss of 
functional PMP22 within the cellular membrane, leading to direct consequences in NCV and the 
overall severity of the neuropathy experienced by patients.   
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While we present no mechanistic evidence that explains how the formation of PMP22 
dimers may negatively impact their cellular trafficking here, we can postulate multiple potential 
mechanisms based on what is known about membrane protein trafficking. The trafficking of WT 
PMP22 is known to be tightly regulated,158 and it is likely that the molecular machinery which 
recognizes properly folded PMP22 may not similarly interact with dimeric PMP22. Additionally, 
PMP22 dimers may be the first step in a more extensive aggregation pathway leading to disruption 
of neuronal function. Beyond the implications for PMP22 biology, we suggest that the methods 
described here could be more broadly applied to membrane proteins misfolding disorders, paving 
the way for future insights into a host of debilitating human ailments. 
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Chapter 4 Collision Induced Unfolding Differentiates Functional Variants of the KCNQ1 
Voltage Sensor Domain 
 
4.1 Introduction 
Membrane proteins maintain cellular homeostasis through regulating signaling, facilitating 
ion transport across biological membranes, and performing a wide array of enzymatic reactions.107 
Disruption of any of these vital functions can cause cellular dyshomeostasis and disease.190 The 
point mutations can significantly alter membrane protein folding, trafficking, and activity, and thus 
many such sequence variants have been linked to disease.145 With recent advances in genome 
sequencing, more human membrane protein variants are being discovered, but the significance of 
these variants is not always readily apparent.191,192 Methods for identifying structural differences 
in these variants is complicated by their insolubility in aqueous solutions and difficulty in obtaining 
pure, high concentration samples.33–35 As there can be hundreds of variants of interest for a 
particular membrane protein,144,145,193 there is an active need for high-throughput compatible 
methods to obtain such structural information on variants of unknown significance (VUS) and 
classify them according to their functional and disease associations. 
Mass spectrometry (MS) is readily capable of overcoming the complexity and challenges 
associated with studying membrane proteins structure.85 In particular, native MS has enabled 
insights into the ligand binding,74,117,194 local lipid environment,118 and protein-protein interactions 
of membrane proteins.162 Coupling ion mobility (IM) separation with mass spectrometry (IM-MS) 
produces information on the orientationally averaged size of ions which allows for the evaluation 
of structural changes within membrane proteins.52,122 The use of IM-MS also facilitates collision 
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induced unfolding (CIU) experiments, in which protein ions are subjected to ramped collision 
energies within the instrument, causing unfolding.100 CIU experiments have been shown to be 
sensitive to lipid binding in membrane proteins,102,168 and classification schemes built on CIU 
experiments,101,195 which have differentiated disulfide bonding patterns134 and ligand binding 
modes.196 However, the use of CIU to differentiate classes of membrane protein variants associated 
with disease have yet to be completely explored. 
Here, we report the first use of CIU to differentiate variants of the 18 kDa voltage sensor 
domain of the KCNQ1 voltage-gated potassium channel. KCNQ1 plays a key role in the tightly 
controlled process of repolarization in cardiac cells197 and the pore opening is modulated by the 
tetraspan integral voltage sensor domain (VSD).198 Specific heritable mutations in the KCNQ1 
VSD are associated with losses or gains of pore activity, where a loss of function (LOF) causes 
Long QT Syndrome (LQTS)199,200 and a gain of function (GOF) causes Short QT Syndrome 
(SQTS).201,202 Both conditions are associated with an increased risk for cardiac arrhythmias and 
sudden cardiac death.203,204 There are over 600 human variants of KCNQ1 associated with 
LQTS.193 However, the significance of many of these variants and the mechanism by which the  
mutations cause disregulation is not well understood. 
In this work we use native IM-MS and CIU to differentiate KCNQ1 VSD variants, each 
having  different disease and functional significance. We first show that wild-type (WT) KCNQ1 
VSD can be liberated from detergent micelles in a manner that retains native like folding in the 
gas-phase. Then we explore the CIU of WT KCNQ1 alongside three mutants:  R231C which is 
associated with SQTS and GOF,205,206 E115G which is associated with LQTS and LOF,207 and 
H126L which was originally a VUS associated with LQTS, but has recently been shown to exhibit 
LOF.146 Our feature detection and comprehensive difference analysis approach highlights changes 
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in the unfolding pathway of WT, GOF, and LOF KCNQ1 VSD variants, where our data support 
the finding that H126L behaves most similar to the LOF type. We demonstrate the ability of CIU 
classification to differentiate WT, GOF, and LOF KCNQ1 VSD variants and show that the H126L 
fingerprints classify as LOF. Further, we quantify the relative stability of the KCNQ1 VSD 
variants through CIU-based stability  measurements and find preliminary evidence that the R231C 
mutation is destabilized relative to WT, which we discuss in the context of cellular data showing 
increased expression and cellular trafficking. Lastly, we project the utility of CIU methods in 
screening large numbers of VUS and discuss the future of such technologies for advancing our 
understanding of membrane protein function. 
 
4.2 Methods 
 
4.2.1 Membrane Protein Sample Preparation 
WT KCNQ1 and the mutant variants H126L, E115G, and R231C were expressed in E. Coli 
and purified using protocols described elsewhere.146 Octaethylene Glycol Monododecyl Ether 
(C12E8) was purchased from Anatrace and ammonium acetates was purchased from Sigma 
Aldrich (St. Louis, MO). For mass spectrometry experiments, 150 µM KNQ1 in buffer of 50mM 
MES, 0.5 mM EDTA, 2 mM TCEP, and 56 µM DDM at pH 5.5 was simultaneously buffer and 
detergent exchanged to 200 mM ammonium acetate buffer,  pH 8.0, containing 0.02% C12E8 (~4 
x CMC)  using 10 kDa Amicon Ultra-0.5 centrifugal filter units (MilliporeSigma, Burlington, 
MA). The final protein concentration used in mass spectrometry experiments was approximately 
25 µM. 
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4.2.2 IM-MS and CIU Experiments 
All IM-MS and CIU data was collected using a Synapt G2 HDMS IM-Q-ToF mass 
spectrometer (Waters, Milford, MA), with a direct infusion nESI source set to positive ion mode. 
Our instrument settings were tuned to generate intact protein ions while completely dissociating 
detergent adducts prior to the IM separator, including appropriately tuned settings for the source 
temperature (30° C), source gas flow (50 mL/min), and the sampling cone (120 V). ). Trapping 
cell wave velocity and height were 116 m/s and 0.1 V. IMS wave velocity and height were 250 
m/s and 15 V.   Transfer cell wave velocity and height were 300 m/s and 10 V, with an accelerating 
potential of 70 V used to dissociate empty micelles and salt clusters. All CIU analyses were 
performed by increasing the trap collision voltage in a stepwise manner 5 – 50 V in 5 V increments, 
as severe signal loss was observed at voltages above 50V for mutant KCNQ1. CIU data from the 
8+ charge state of KCNQ1 was extracted into a text-based format using TWIMExtract132, then 
processed and analyzed using CIUSuite 2.1.134 Data processing included three rounds of 2D 
Savitzky-Golay smoothing with a window of five bins and interpolation of the collision voltage 
axis by a factor of four.  
Protein stability values, referend to here as CIU50 values, were extracted as described 
previously.168 For mutant KCNQ1, excess surfactant related noise was noted in the lower drift time 
region from 35 - 50V. This noise was removed from the text-based files manually to eliminate any 
biased contributions to RMSD analysis, as shown in Figure IV-2. To ensure the noise removal did 
not alter the reported protein unfolding trajectory, CIU50 analysis was performed before and after 
noise removal, and reported CIU50 values were identical. Classification of these denoised data 
was performed using the “All Data” mode of CIUSuite 2.1, with automatic feature selection. The 
algorithms that enable our CIU classification analysis are described in detail elsewhere.101,134,168  
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4.3 Results and Discussion 
 
4.3.1 IM-MS of KCNQ1 VSD 
Sequence variants associated with toxic 
LOF or GOF occur throughout the sequence of 
the KCNQ1 VSD, as shown in Figure 4-1A.146 
For our assay, we chose mutations from disparate 
locations in the proteins sequence, with E115G in 
soluble helix S0, H126L in membrane spanning 
helix S1, and R231C in membrane spanning helix 
S4. The KCNQ1 potassium channel functions as 
a tetrameric complex, where four pore domains 
interact to form a functional channel.198 The 
tetraspanning VSD of KCNQ1 is connected to the 
pore domain by a flexible linker between helices 
S4 and S5, as well as a 99 residue soluble domain 
before helix S1. The VSD is positioned at the 
periphery of the pore, and as such is not thought to 
be heavily involved in pore oligomerization.198   
 Figure 4-1B shows an example native IM-
MS dataset for WT KCNQ1, where a range of 
signals can be detected after successful dissociation 
of the detergent from the associated membrane protein of interest. MS analysis and charge state 
Figure 4-1. Native IM-MS of the KCNQ1 VSD. A. 
Sequence and structure of the KCNQ1 VSD with residues 
known to mutate and produce disease phenotypes 
associated with LOF (red) or GOF (blue). Variants E115G, 
H126L, and R231C are studied in this work. B,C. 
Representative mass spectra and IM-MS data for WT 
KCNQ1 at 80V trap collision voltage. One distribution of 
charge states, 5-10+, is observed for all variants 
corresponding to KCNQ1 VSD monomers (Figure IV-3). 
The charge state envelope and compactness of signals in 
IM space indicate native like folding, and the 8+ charge 
state (orange) was chosen for further analysis. 
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assignment of these signals reveals an ion population with an intact mass of 18208 ± 44 Da, which 
agrees well with the expected sequence mass of a KCNQ1 VSD monomer, 18158 Da. The range 
of charge states we observe for KCNQ1, 5-10+, as well as the compactness of the signals in the 
two-dimensional IM-MS data set, indicate native like structure for the gas phase protein (Figure 
4-1C, IV-3). Notably, for all four sequence variants studied here we observe monomodal IM 
distributions at low collision energies for KCNQ1 VSD and find no evidence of oligomeric species 
(Figure IV-1). As has been documented for other IM-MS experiments of membrane 
proteins,40,78,119,138,168 we observe noise signals related to detergent and salt clusters that persist 
despite sample and instrumental optimization (Figure 4-1C).  These noise signals were more 
intense in the IM-MS datasets recorded for the mutant protein forms, perhaps due to lower protein 
concentrations used in these experiments in comparison to those involving WT. The 8+ charge 
state of the KCNQ1 VSD (orange) was chosen for subsequent CIU experiments as it exhibits a 
good balance between high signal intensity, low noise overlap, and low charge state.  
 
4.3.2 Differences in CIU features correlate to KCNQ1 VSD variant function 
CIU analysis often focuses on defining regions of stability, or features, within the recorded 
data.  CIU feature analysis has been used to characterize domain level unfolding208 and 
noncovalent interactions106 within proteins, and we employed such an approach to interrogate the 
CIU data collected for the four KCNQ1 VSD sequence variants discussed above. CIU fingerprints 
of the KCNQ1 VSD 8+ charge state were collected in triplicate using a collision voltage range of 
5-50V. While the interference from noise signals was minimal for WT KCNQ1 VSD, each variant 
dataset contained noise appearing primarily at larger collision voltage (CV) values and  at drift 
times shorter than those occupied by the protein ion signals tracked in our experiments (Figure IV-
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2). These noise signals did not alter the CIU features detected in our fingerprints; however, to 
eliminate any bias in our  workflow, detergent noise was uniformly removed as described in the 
methods section for all datasets interrogated in this study. Figure 4-2 shows the de-noised CIU 
fingerprints (top) and detected features (below) for each KCNQ1 variant. For WT KCNQ1 VSD 
fingerprints, three features are observed with median drift times of 16.4 ± 0.3 ms,  19.9 ± 0.0 ms, 
and 21.8 ± 0.0 ms. Similarly, the GOF variant R231C fingerprints also exhibit three features with 
median drift times comparable to those observed for WT at 17.0 ± 0.3 ms,  20.0 ± 0.3 ms, and 22.7 
± 0.2 ms respectively. The two LOF variants, E115G and H126L, show two features each at drift 
times of  17 ± 0.0 ms and  21.0 ± 0.0 ms, and 16.4 ± 0.3 ms and  20.4 ± 0.5 ms, respectively. 
The most compact CIU feature occurs at similar starting drift times for each KCNQ1 VSD 
form studied here, which indicates that there are no significant differences in the orientationally 
averaged size of the gas phase structures at low collision energies. However, differences were 
detected in the overall number of features occurring between 5-50V across the mutants studied 
here, where specifically we detect two CIU features over the above voltage range for E115G and 
Figure 4-2. CIU fingerprints of KCNQ1 VSD variants. (Top) Fingerprints were collected for the 8+ charge state in triplicate for 
WT, R231C, E115G, and H126L variants, from 5-50V, and then denoised and averaged to produce the images shown here. 
(Bottom) Automated feature detection of the fingerprints finds three discrete features between 5-50V for WT and R231C, and 
two discrete features for E115G and H126L. The similarity in starting drift times of the four fingerprints indicate all forms begin 
at similar orientationally averaged sizes. 
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H126L, and three features for WT and R231C. The similarity observed in the CIU data recorded 
for E115G and H126L is further apparent in the similar range of voltages values over which their 
features persist, as seen in Figure 4-2. These results mimic previous cellular assays which classify 
these mutants together in terms of their LOF severity.146  
 
4.3.3 Quantifying differences in CIU fingerprints of KCNQ1 VSD variants through 
comprehensive analysis (RMSD) 
 To further investigate the relative differences between KCNQ1 VSD variants, we 
performed comprehensive difference analyses using a root mean squared deviation (RMSD) 
approach. Such analyses have been used previously to quantify differences detected in CIU data 
recorded for antibodies based on glycosylation state.166 Figure 4-3A shows a difference plot for 
the averaged CIU fingerprints recorded for E115G and H126L KCNQ1 mutants. We find an 
overall RMSD across these CIU fingerprints to be 6.6%, which is similar to RSMD values 
encountered for comparisons between KCNQ1 technical replicates alone (a range from 6.4% to 
9.5%). In contrast, Figure 4-3B shows a similar CIU difference plot generated for averaged H126L 
and R231C fingerprints. In this comparison, the regions of differences are more pronounced, with 
stronger R231C signal apparent at longer drift times relative to H126L. Unsurprisingly, we find a 
larger overall RMSD for this comparison, resulting a value almost three times that for the analysis 
shown in Figure 4-3A, at 18.6%.  
A comprehensive comparative analysis of our KCNQ1 variant CIU datasets reveals those 
mutants that are most and least similar to one another (Figure 4-3).  In this cross-comparison, we 
see differences 2-3 times greater than the baseline RMSD values computed through the analysis 
of technical replicates of identical samples (think bordered boxes, values range from 6.4% for WT 
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to 9.5% for H126L), as indicated by the color scale in 
Figure 4-3C. Specifically, we observe no significant 
differences for the CIU data recorded for  H126L and 
E115G, while the RMSD recorded for the comparisons 
of H126L and R231C CIU data is significant. 
Interestingly, the datasets exhibiting the largest RMSD 
value in our cross-comparison CIU analyses are WT 
and R231C, producing a value of 24.8%, despite the 
similarities observed between these data in Figure 4-
2(also see Figure IV-4). A careful analysis of our 
comparative CIU data indicates that R231C is 
destabilized relative to WT and other KCNQ1 VSD 
variants. Overall, the comprehensive difference 
analysis shown in Figure 4-3C indicates significant 
differences between R231C and all other variants, as 
well as similarities between E115G and H126L. These 
results align with the fact that R231C is the lone GOF 
mutant studied here, as well as prior trafficking and 
cellular expression data recorded for this variant (Figure IV-5). 
Figure 4-3. Comprehensive difference analysis of 
KCNQ1 VSD variants CIU fingerprints, N = 3 for 
each variant. A, B. Example difference plots of a 
low RMSD comparison (E115G and H126L, 6.6%) 
and high RMSD comparison (H126L and R231C, 
18.6%). C. Pairwise comparisons of WT, E115G, 
H126L, and R231C. RMSD baseline values are 
shown in the thick bordered boxes. Differences of 2-
3x above the baseline are considered significant. All 
difference plots are shown in Figure IV-4. 
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4.3.4 CIU Classification of phenotypic function 
As shown in Figure 4-1A, there are many possible 
disease-associated variants of the KCNQ1 VSD. 
Additionally, some former VUS forms of KCNQ1 
were found to exhibit WT-like function, indicating 
they may not contribute to disease.146 To probe the 
ability of CIU to differentiate these phenotypes, we 
endeavored to build and test a three-way CIU 
classification scheme with the KCNQ1 variants 
studied here, grouped into the following classes: 
WT, gain of function (GOF), and loss of function 
(LOF). We started with at least three denoised 
replicates each of WT, E115G, and R231C KCNQ1 
VSD used in the training dataset to represent each 
functional phenotype: WT, LOF, and GOF, 
respectively (Figure 4-4A). Our efforts identified 
the most differentiating region within the datasets as 
those between 10-20V,  and cross validation 
revealed that classifiers using only the 15V datasets 
produced the greatest assignment accuracy (0.81 
AUC-ROC, Figure 4-4A inset). 
 A classification scheme was built using the 
chosen 15V data and the results plotted linear 
Figure 4-4. CIU based classification of KCNQ1 VSD 
functional variants A. Each voltage is scored on its 
ability to differentiate the three classes: WT, LOF, and 
GOF, using at least three WT, E115G, and R231C 
replicates. All voltages were used in a ‘leave one out’ 
cross-validation test, shown in the inset plot, where we 
tracked the accuracy achieved with the training data 
(blue),non-training data (green), and the area under the 
ROC curve (red) as a function of the number of voltages 
included in the classification scheme. These tests 
indicated one voltage (*) was best for classification B. 
Using the voltage indicated in A, the training data set is 
plotted in linear discriminant and shows clear separation 
of the data into the three classes. C. The probability of 
assignment for replicates not part of the training data set 
is displayed in a bar chart. Each replicate is correctly 
assigned, including replicates of the H126L variant for 
which no example was included in the training set. 
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discriminant space in Figure 4-4B, where gray data points indicate the WT phenotype, red indicate 
the LOF phenotype, and blue indicate the GOF phenotype. To test the performance of our 
classification scheme, we input CIU replicates to our classifier that were not part of the training 
dataset as unknowns. The classification scheme was then used to analyze these unknowns, and the 
resulting probabilities associated with assigning each of these datasets to one of the three KCNQ1 
classes defined above is shown in Figure 4-4C. Data for WT, E115G, and R231C all classify as 
expected, producing an assignment probability of at least 60% for the correct class. In order to 
further test our classifier, we employed it to analyze CIU data collected for the H126L variant, 
none of which was in our training data.  Our H126L CIU data classifies, as expected, as an LOF 
KCNQ1 variant,146 with a total class assignment probability of 60 ± 2%. As such, our results both 
support prior assignment of H126L as an LOF KCNQ1 variant, and demonstrate the ability of CIU 
fingerprints to classify KCNQ1 VSD mutants based on their associated phenotypic function. 
 
4.3.5 CIU reveals evidence of mutant destabilization 
To further probe and quantify differences among KNCQ1 VSD variants relative to WT, 
we performed CIU50 analysis in order to quantify stability differences among the mutants studied 
here. Due to the different number of CIU features detected across KCNQ1 VSD variants, WT and 
R231C fingerprints were fit with two sigmoidal curves and E115G and H126L fingerprints were 
fit with one sigmoidal curve, as shown in Figure 4-5A, during our analysis. As such, all 
comparisons here will focus on the first CIU50 value recorded for WT and R231C variants. Figure 
4-5B summarizes the average CIU50 values extracted for the first CIU transitions shown in Figure 
4-5A. We record the stability of the WT as 25.8 ± 1.5V, which is within error of the stability values 
we observe for the two LOF mutants E115G and H126L at 24.8 ± 0.3V and 24.0 ± 1.3V 
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respectively. The GOF mutant, R231C, exhibits CIU50 values 
for the first transition that occur at significantly lower energies 
relative to the other three variants, producing a value of 17.7 ± 
1.6V. In addition, the CIU50 we record for the second CIU 
transition for R231C also occurs at lower average voltages 
than WT, but the experimental error we compute for these 
values renders the difference insignificant , with R231C 
producing a value of 30.0 ± 4.9V and WT having a CIU50 of 
37.0 ± 3.3V.  
Overall, we take these CIU50 data to support the 
observations made in Figures 4-2 and 4-3, in that the GOF 
mutant R231C produces CIU data that is significantly different 
from that observed from either WT or LOF KCNQ1 mutants, 
primarily driven by the destabilization of R231C. This data is 
interesting to consider in the context of cellular assays which 
demonstrate that R231C KCNQ1 is a super-trafficker, and is 
highly-expressed relative to the other variants studied here 
(Figure IV-5). It is important to note that the construct used in 
our MS assays only includes the VSD of KCNQ1, whereas 
cellular assays track the entire KCNQ1 sequence, which is 
tetrameric in its native state. As such, we propose that the 
destabilization of the GOF R231C VSD variant may be 
somewhat ameliorated in the tetrameric state of KCNQ1, the 
Figure 4-5. CIU50 stability analysis of 
KCNQ1 variants. A. Sigmoidal curves 
are fit between identified features to 
describe the transition, where WT and 
R231C have two transitions and E115G 
and H126L have one transition. B. A bar 
chart of average CIU50 values extracted 
from the inflection point determined for 
each first transition detected, N = 3. Gray 
is WT, blue is GOF, and red is LOF. 
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formation of which would be favored at high cellular concentrations.  In addition, the protein-
protein interactions formed with cellular trafficking machinery may not depend on the VSD region 
of KCNQ1. Future native IM-MS assays of full length KCNQ1 may further reveal how the 
destabilization of  R231C KCNQ1 results in increased trafficking and GOF. 
 
4.4 Conclusions 
CIU is amenable to the characterization of membrane proteins and many past studies have 
focused mainly on its ability to characterize  lipid binding behavior in such  systems.94,106,168 Here 
we describe a workflow for using CIU to classify membrane protein variants according to their 
associated functional role within a given phenotype using the KCNQ1 VSD as a model system. 
We first performed comprehensive difference analysis on three types of KCNQ1 VSD variants: 
WT, GOF, and LOF, and found strong evidence to support clustering our CIU data along the 
known functional consequences associated with each variant analyzed. We then used an 
established machine learning approach to build a classification scheme using CIU data recorded 
for example WT, GOF, and LOF variants, and found that this approach was reliably able to group 
further CIU data into classes based on the above phenotypes. Lastly, we explored the stability 
differences associated with  these variants using CIU50 analysis and found evidence that the GOF 
R231C mutant is destabilized relative to WT and LOF variants for the KCNQ1 VSD.  
Additionally, Native IM-MS is a method compatible with high throughput analyses, as is 
our classification workflow. Using the methods presented here, we estimate that the native IM-MS 
data collection needed to classify a VUS with our scheme could be performed in triplicate within 
6 minutes. Clearly, our KCNQ1 classification scheme would be strengthened by the addition of 
more known variants for each class prior to testing such  high throughput analyses, where we 
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envision that only the  most differentiating regions of CIU space need be collected for each 
unknown interrogated. We also project that this same type of CIU classification scheme could be 
deployed to detect the five LOF classes described previously for KCNQ1.146 Overall, we project 
that the workflow presented here could be expanded to broadly classify KCNQ1 VUSs, or be 
expanded to accommodate a wide range of membrane protein systems possessing variants that 
lack functional annotation.  
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Chapter 5 Systematically Studying Membrane Proteins Liberated from Different 
Solubilization Techniques  
 
5.1 Introduction 
 Membrane proteins are important biological and pharmacological analytes that play key 
roles in maintaining cellular homeostasis and represent 60% of current therapeutic targets.3,107 
Membrane proteins exist in complex cellular environments where their function can be modulated 
by interactions with other proteins and lipids.141,209 Due to their complex native environments and 
intrinsic hydrophobicity, the purification of membrane proteins requires the use of solubilization 
agents and often results in low protein yields.35 These factors make obtaining high resolution 
structural information on membrane proteins difficult and they are currently underrepresented in 
structural databases in comparison to their soluble counterparts.33,34 Further, the function and 
structure of membrane proteins has been shown to be sensitive to the solubilization technique 
used,69,210,211 resulting in increased use of more native-like lipid mimetics for membrane protein 
solubilization. 
 Recently, native mass spectrometry (nMS) has been demonstrated capable of analyzing 
membrane protein samples from a variety of solubilization methods to reveal structural and 
functional information.54,85 In nMS workflows, membrane proteins undergo nano-electrospray 
ionization (nESI) while protected by their solubilization agents before being collisionally ejected 
from these agents inside the instrument. While the majority of the work in this field has been 
performed by liberating gas phase membrane proteins from detergent 
micelles,40,78,93,96,97,122,137,168,194 membrane proteins housed in other solubilization techniques such 
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as amphipols,119 bicelles,119 nanodiscs,52,118,162,212,213 styrene maleic acid lipid particles 
(SMALPs),214 and biological membrane vesicles161 have all been successfully detected through 
nMS. The use of these techniques with nMS has enabled the study of elusive membrane protein 
characteristics such as annular lipid binding,118 oligomerization pathways,212 and complex 
formation which span both the inner and outer cellular membranes.215 The addition of ion mobility 
(IM) separations to mass spectrometry allows for the measurement of the orientationally averaged 
size of gas phase membrane proteins,99 and also enables collision induced unfolding experiments 
(CIU). In CIU experiments, the protein is collisionally activated by the stepwise ramping of an 
accelerating potential, which causes it to unfold. The trajectory by which a gas phase analyte 
unfolds can be tracked through the generation of CIU fingerprints, and recent software 
advancements have presented workflows for the automated analysis of CIU fingerprints to inform 
on the relative gas phase stability of ions.133 While multiple studies have used IM-MS and CIU to 
elucidate the structural changes and relative stability of membrane protein 
complexes,76,94,106,122,136,168,216 to our knowledge the use of CIU on membrane proteins has been 
previously limited to membrane proteins solubilized in detergent micelles. 
 Here, we employ IM-MS and CIU to systematically study membrane proteins solubilized 
by multiple techniques. We first describe the use of IM-MS to screen nanodisc lipid conditions 
towards the optimization of dimeric complex incorporation for the 18 kDa integral translocator 
protein (TSPO). Given the ability of IM-MS and CIU to access structural information about 
membrane proteins, we our second set of experiments probe the ability of IM-MS and CIU to 
capture differences in the membrane proteins associated with their solubilization agents. We do 
this through collecting CIU fingerprints for model protein systems which have been solubilized 
using at least two different methods, including detergent micelles, sphingomyelin and cholesterol 
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rich (SCOR) bicelles,188 and lipid nanodiscs. Our three model protein systems, chosen based on 
their representation of diverse membrane protein structure, are the monotopic cytochrome P450 
3A4 protein, the dimeric L16P variant of the integral peripheral myelin protein (L16P PMP22), 
and a form of WT PMP22 which contains a large, 11 kDa soluble tag (WTtag PMP22). We find 
that significant differences exist between all CIU datasets collected for these proteins as a function 
of their solubilization agents. Further, we find that these differences emphasize the  importance of 
careful evaluation of solubilization agents on a protein to protein basis to best preserve gas phase 
structure. We conclude by discussing how the data presented should be considered during 
membrane protein nMS optimization and proposing further experiments to elucidate the role of 
solubilization agents in gas phase protein structure. 
 
5.2 Methods 
 
5.2.1 Membrane Protein Sample Preparation 
 TSPO bearing the A138F point mutation was purified and expressed using established 
protocols from Rhodobacter sphaeroides.128 CYP 3A4 was expressed in E. Coli and purified using 
protocols described elsewhere.217–219 PMP22 WTtag and the L16P mutant variant were expressed 
in E. Coli. using protocols adapted from Schlebach et al.220 For WTtag PMP22, the protein did not 
undergo the final thrombin cleavage step. Octaethylene glycol monododecyl ether (C12E8) and n-
Dodecyl-β-D-Melibioside (DDMB) were purchased from Anatrace, Octyl β-D-glucopyranoside 
(OG),  membrane scaffold protein 1D1(-), ammonium acetate, sodium chloride, 
tris(hydroxymethyl)aminomethane (tris), sodium azide, and ethylenediaminetetraacetic acid 
(EDTA) were purchased from Sigma Aldrich (St. Louis, MO).  The lipids 1,2-dioleoyl-sn-glycero-
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3-phosphoethanolamine [DOPE], 1-palmitoyl-2-oleoyl-glycero-3-phosphocholine [POPC], 1,2-
dipalmitoyl-sn-glycero-3-phospho-L-serine [DMPS], and 1,2-dimyristoyl-sn-glycero-3-
phosphocholine [DMPC] were purchased from Avanti Polar Lipids (Alabaster, AL). All 
membrane proteins were screened for appropriate detergent conditions.85 
 Samples housed in detergent micelles were simultaneously detergent and buffer exchanged 
using 10 kDa Amicon Ultra-0.5 centrifugal filter units (MilliporeSigma, Burlington, MA), except 
TSPO which was exchanged using a 100 kDa Amicon Ultra-0.5 centrifugal filter units 
(MilliporeSigma, Burlington, MA). Starting and ending buffers and detergents conditions prior to 
native MS are as follows: 30 μM TSPO was exchanged from 50 mM Tris, 150 mM NaCl , 0.20% 
DM (N-dodecyl β-D-maltoside), pH 8.0 to 40 mM OG , 200 mM ammonium acetate, pH 8.0, 50 
µM PMP22 was exchanged from 50 mM Tris, 0.15% DM, 15 mM imidazole, and 1 mM TCEP, 
and 0.1% DDM, pH 8.0, to 0.02% C12E8 (~4 x CMC), 200 mM ammonium acetate, pH 8.0, 36 
µM CYP 3A4 was exchanged from 40 mM potassium phosphate, 20% glycerol,  pH 7.4 to 40 mM 
OG, 200 mM ammonium acetate, pH 7.4. Samples housed in SCOR bicelles were prepared as 
described in the supplemental methods and were then buffer exchanged using 10 kDa Amicon 
Ultra-0.5 centrifugal filter units. Bicelle samples were not detergent exchanged and the DDMB 
concentration was held at 1 x CMC to preserve the bicelles q ratio (0.33) Specifically, 40 µM 
PMP22 in 10 mM acetate buffer (pH 5.0) containing 100 mM NaCl, 0.2 % SCOR bicelle (q = 
0.33), 1 mM EDTA, 5 mM TCEP, and 0.3 mM DDMB was exchanged into 200 mM ammonium 
acetate, 0.3 mM DDMB, pH 8.0 using 10 kDa Amicon Ultra-0.5 centrifugal filter units. TSPO 
samples were incorporated into nanodiscs as described in the supplemental methods and were then 
buffer exchanged using Micro Biospin6 spin columns (BioRad, Hercules, CA) from standard MSP 
buffer to 200 mM ammonium acetate, pH 7.4. Add DMPC, DPPS. CYP 3A4 samples were 
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incorporated into POPC nanodiscs with the scaffold protein MSPE3D1 using a microfluidic 
device.221  
5.2.2 Native MS and CIU Experiments 
All IM-MS and CIU data were collected using a Synapt G2 HDMS IM-Q-ToF mass 
spectrometer (Waters, Milford, MA), with a direct infusion nESI source set to positive ion mode. 
Our instrument settings were tuned for each protein system and mimetic to generate intact protein 
ions while completely dissociating detergents, lipids and scaffold protein prior to the IM separator, 
including appropriately tuned settings for the source temperature (30-40° C), source gas flow (50 
mL/min), and the sampling cone (120 V). The traveling wave height and wave velocities in the 
trap, IM, and transfer region, as well as the helium cell flow rate, were identical for each protein 
system across mimetics. For TSPO, the trapping cell wave velocity and height were 116 m/s and 
0.1 V. IMS wave velocity and height were 700 m/s and 32.5 V. For PMP and CYP, trapping cell 
wave velocity and height were 116 m/s and 0.1 V, IMS wave velocity and height were 250 m/s 
and 15 V, transfer cell wave velocity and height were 300 m/s and 10 V. An accelerating potential 
of 70 V in the transfer region was used to dissociate empty solubilization agents for all systems 
except CYP in nanodiscs, which only required 10 V. Experimental collision cross section analysis 
was performed by using IMSCal-19v4, a program written in C, and, where possible, theoretical 
cross sections were calculated from crystal structures14 and homology models178 using 
IMPACT.99,222 All CIU analyses were performed by increasing the trap collision voltage in 5 V 
increments across ranges tuned for each system. CIU data from selected charge states were 
extracted into a text-based format using TWIMExtract,132 then processed and analyzed using 
CIUSuite 2.1.133,221 Data processing included two or three rounds of 2D Savitzky-Golay smoothing 
with a window of five bins and interpolation of the collision voltage axis by a factor of four.  
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5.3 Results and Discussion 
 
5.3.1 IM-MS of TSPO from micelles and nanodiscs 
TSPO is a penta-span integral mitochondrial protein proposed to be involved in cholesterol 
transport and lipid transport.127,223 This protein is highly expressed in areas of inflammation and is 
associated with multiple disease states, including traumatic brain injuries and cancer.16,129,224 TSPO 
is thought to perform its function as a homodimeric complex and previous native mass 
spectrometry studies have identified lipids endogenously bound to the dimer protein.168,194 
Although it was found to bind multiple lipids across different lipid classes,168 all previous nMS 
studies of TSPO have been performed using detergent micelles. Given its proposed roles in lipid 
transport, we considered TSPO to be a good model system for investigating the effects of 
solubilization agents on nMS datasets. Here, we report the first nMS studies of TSPO liberated 
from membrane mimetics, describe how nMS can be used to inform optimization process for 
obtaining biologically relevant protein complexes and discuss the noise related challenges 
presented by each method. 
Figure 5-1A, B shows example nMS and IM-MS datasets for TSPO liberated from micelles 
composed of the detergent OG. From these spectra, monomeric and dimeric TSPO can be observed 
across the charge state ranges of 4 - 7+ and 8 – 11+, respectively. The CCS for 9+ TSPO dimer, 
2751 Å2, agrees well with the expected CCS based on the available X-ray structure, 2741 Å2 (PDB 
4UC1).14 While there is literature detailing the purification of TSPO into detergent micelles,128 to 
our knowledge no protocol has been optimized for incorporating TSPO into a nanodisc. We 
screened a range of lipid conditions for TSPO incorporation and found that despite optimizing the 
protein:scaffold:lipid ratio, nanodiscs formed from the standard net neutral head group lipid, 
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DMPC, only allowed for the detection of monomeric TSPO (Figure V-2).225 This is an interesting 
observation in the context of previous studies that observed potential destabilization of TSPO 
dimeric complexes upon POPC binding.168 Additionally, nMS of nanodiscs formed with the net 
negatively charged lipid DPPS showed significant amounts of dimeric complex but required 
excessive trap collision voltages of 200 V to dissociate the protein from the nanodisc. Nanodiscs 
formed with TSPO using the net neutral lipid DOPE were both amenable to nMS analysis and 
exhibited dimeric complexes, and were thus determined to be the optimal composition for further 
experiments.  
The nMS and IM-MS data for TSPO liberated from DOPE nanodiscs are shown in Figure 
5-1C, D. Comparing these optimized nanodisc samples to the detergent micelle nMS data, key 
Figure 5-1. Native ion mobility-mass spectrometry of the TSPO from micelles and nanodiscs. A, B. Mass spectra and IM-MS 
data of TSPO liberated from OG detergent micelles shows mainly dimeric protein from the charge states 8-11+ and some 
monomeric protein at charge states 4-7+. Endogenously bound lipid can also be observed from the dimeric complexes, as well 
as broad noise signals related to empty detergent micelles. C, D. Mass spectra and IM-MS of TSPO liberated from the optimized 
nanodisc of POPE lipids shows relatively less dimer than the OG micelles at reduced charge states of 7-10+, and more 
monomeric protein at charge states of 4-7+. Lipids are bound to both monomeric and dimeric protein in high stoichiometries, 
indicating they are retained from the nanodisc as it dissociates. Noise related to overlapping to the scaffold protein and its 
retained lipid can interfere with the TSPO signals. 
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similarities and differences can be observed. First, the arrival times in IM space are generally 
comparable for monomeric and dimeric species, indicating similar levels of compactness in the 
gas phase structures. Second, while dimeric complexes can be observed, the intensity of these 
complexes in the optimized nanodisc conditions is much lower. Additionally, these dimer signals 
for the nanodisc nMS experiments are slightly shifted to lower charge states, which can be 
explained considering the potential differences in solvent accessible areas of the protein between 
the two methods. Lastly, vastly different noise signals exist between the two methods which 
present unique challenges. The micelle data shows a large region affected by noise signals which 
creates an elevated baseline in the nMS, and is caused by the polydisperse empty micelles (Figure 
5-1AB). The nanodisc data has more discrete noise signals related to the membrane scaffold 
protein and various lipid:scaffold complex stoichiometries, which can overlap with signals of 
interest in both mass to charge and arrival time space (Figure 5-1D). These observations highlight 
the different challenges associated with each technique as well as the importance of optimizing 
nanodisc incorporation protocols for protein complexes.  
 
5.3.2 Studying the effects of solubilization technique on CIU of monotopic membrane protein 
CYP 3A4 
While the field of membrane protein nMS has largely focused on multi-pass integral 
proteins, such as TSPO, recent efforts have explored how these techniques can be extended to 
peripheral proteins.226 These proteins possess large aqueous domains in addition to regions which 
interact with but do not span, the lipid bilayer and their dual nature can complicate their biophysical 
characterization.227 For this reason, single pass and monotopic membrane proteins, which are 
embedded in the membrane with a single alpha helix, are commonly studied in forms where the 
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sequence is truncated to exclude the alpha helix which can alter the structure of membrane 
associated domains.227 However,  to study the more biologically relevant protein form with the full 
sequence, a method must be capable of handling the solubilization agents needed to retain the 
native helix structure. Here, we use the full length monotopic protein cytochrome P450 as a model 
system for testing the effects of micellar and nanodisc based solubilization techniques on the gas 
phase stability of proteins possessing large aqueous domains. 
The CYP family of proteins are enzymes important for the process of drug metabolism.217 
They bind a wide variety of drugs and have been noted in the past to also bind detergent molecules. 
228 We therefore screened for nMS detergent conditions in which there was no bound detergent 
peak present, which led us to use the detergent OG for nMS of CYP 3A4. Figure V-3A shows 
monomeric CYP 3A4 liberated from OG micelles at charge states of 13-17+, and while the peaks 
are broad relative to soluble systems of comparable size,229 no distinct detergent binding is 
observed. Mass analysis of centroid of these peaks corresponds to the mass of CYP 3A4 plus its 
heme cofactor, indicating we mainly see the holo protein state. CYP 3A4 has been previously 
studied in nanodiscs, and multiple incorporation protocols have been published.230,231 In Figure V-
3B, we show CYP 3A4 incorporated into POPC nanodiscs with the MSP3ED1 scaffold protein 
which was produced using a microfluidic device.219 Peaks for CYP 3A4 liberated from the 
nanodisc are significantly more resolved than those from micellar conditions, and allow for the 
identification of apo and holo CYP 3A4, as well as retained lipid bound states. These monomeric 
CYP 3A4 peaks occur at charge states identical to the micellar data at 13-17+ and both IM-MS 
data sets show compact signals indicating native-like folding. CCS measurements from the 16+ 
holo peak do show small differences in orientationally averaged size, with micellar CYP 3A4 at 
5022 ± 26 Å2 and nanodisc CYP 3A4 at 4785 ± 25 Å2. We propose that these differences, as well 
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as the broadness of the micellar nMS peaks, are related to increased glycerol, salt, or detergent 
adduction in micellar CYP 3A4 samples.   
To further investigate the differences between CYP 3A4 solubilized in micelles and 
nanodiscs, we next performed CIU experiments on the 16+ holo charge state as shown in Figure 
5-2. CIU fingerprints were generated in triplicate for nanodisc CYP 3A4 and, while multiple 
replicates of CYP in OG micelles were collected, data quality was too poor to analyze in all but 
one. Figure 5-2A shows the five features and four transitions observed for the CYP 3A4 micellar 
replicates, with features beginning at 17.0 ms and 
 
Figure 5-2. CIU of CYP 3A4 liberated from detergent micelles and nanodiscs. All fingerprints shown are for the 16+ holo state. 
A. Feature detection analysis of CYP liberated from OG micelles, N = 1, shows features of 17.0, 20.8, 22.0, 25.2, and 28.3 ms. 
CIU 50 transitions fit to these features occur at 26.9, 38.4, 48.0, and 56.9 V. B. Feature detection analysis of CYP liberated from 
POPC nanodiscs with the MSPE3D1 scaffold, N = 3, show features of 16.5 ± 0.3, 19.2 ± 0.2, 20.8 ± 0.2, 24.1 ± 0.5, and 27.2 ± 0.3 
ms. CIU 50 transitions fit to these features occur at 24.1 ± 1.5, 31.6 ± 1.5, 38.5 ± 0.7, and 47.7 ± 0.7 V. C. RMSD plot of the 
micellar replicate subtracted from the averaged nanodisc fingerprint for CYP 3A4 shows an RMSD of 32.2%. 
a first transition from the most native-like state occurring at 26.9V. Figure 5-2B shows the average 
fingerprint for CYP 3A4 generated from the three POPC nanodisc replicates, which also fit to five 
features and four transitions. The first CYP 3A4 nanodisc features occurs at 16.5 ± 0.3 ms and the 
transition from this first, most native-like feature to the first unfolded feature occurs at 24.1 ± 1.5V. 
These data show that the protein undergoes a similar unfolding trajectory regardless of it being 
solubilized in OG micelles or POPC nanodiscs, however, the starting drift time for the CIU 
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fingerprint is slightly longer for the micelles. This aligns with the CCS difference observed above 
and could be a result of either increased adduction or a more unfolded starting state. However, the 
CIU50 transitions for the micellar CYP 3A4 are all shifted to higher CV relative to the nanodisc 
CYP 3A4, which indicates that the micellar CYP 3A4 is stabilized relative to nanodisc. This can 
also be observed in the comprehensive difference analysis plot in Figure 5-2C, where the blue 
regions characteristic of the micellar CYP fingerprint are concentrated to the right of the nanodisc 
fingerprints (red). As the lipid environment of CYP 3A4 is known to be important for its 
function,211 we would expect that the protein released from the lipid environment be more stable 
than that from the micelle. Instead, what we propose to observe here is the increased adduction of 
CYP 3A4 under the detergent conditions causes enhanced stability relative to the nanodisc. 
Adduction of soluble proteins has been previously shown to stabilize soluble proteins,232 and thus 
it extends that the same phenomenon can occur for membrane proteins. Further work with this 
system will include additional detergent screening and buffer conditions to minimize adduction.  
 
5.3.3 Comparing the unfolding trajectories of transmembrane protein complexes between 
SCOR bicelles and detergent micelles 
Membrane proteins exist in a complex lipid environment where they can interact with a 
variety of different lipid classes.2,141 While the nanodiscs we have discussed so far have been 
comprised of one lipid, more biologically relevant bilayer mimetics have been recently 
described.188,211,214 One example is sphingomyelin and cholesterol rich (SCOR) bicelles which aim 
to mimic the more ordered, cholesterol dense regions of membranes.188 As lipids have been known 
to influence the oligomeric complex formation of transmembrane proteins,40 we chose to study a 
dimeric protein complex of peripheral myelin protein 22 (PMP22) liberated from SCOR bicelles 
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and compare the stability of these complexes to those liberated from detergent micelles. We report 
the first CIU measurements of protein liberated from SCOR bicelles. 
Drawing from previous findings in Chapter 3 related to the relative amount of dimer 
complex present in nMS of PMP22 SCOR bicelle samples, we chose to evaluate the L16P mutant 
of PMP22. We also adopted the detergent screen and bicelle preparation protocols from Chapter 3 
but extended the analysis to include performing CIU experiments with the L16P PMP22 liberated 
from SCOR bicelles. Figure V-4 shows example nMS and IM-MS data sets for L16P PMP22 
liberated from C12E8 micelles and SCOR bicelles. In both samples, signals corresponding to 
monomeric protein, dimeric protein, or both are present at identical charge states. For PMP22 
L16P liberated from the SCOR bicelles, considerable noise is present in the lower mass to charge 
range. The 13+ dimeric PMP22 charge state was chosen for CIU analysis due to its intensity and 
the minimal noise overlap. CCS analysis of the for the 13+ dimeric charge state of PMP22 showed 
the protein liberated from SCOR bicelles to be more compact, at 2653 ± 13 Å2, versus 2953 ± 9 
Å2 from C12E8 micelles (N = 1). This CCS analysis is preliminary evidence showing that gas 
phase L16P PMP22 dimers adopt a different, more compact starting conformation when liberated 
from SCOR bicelles than those liberated from C12E8 micelles, presumably due to interactions 
with the lipids or different solution phase structures.  
The 13+ dimeric L16P PMP22 charge state was chosen for CIU analysis due to its intensity 
and the minimal noise overlap. Figure 5-3 shows the average of three replicates for both micellar 
and bicellar L16P PMP22 with detected features and CIU50 transitions. Interestingly, the two 
fingerprints are quite different in terms of the number of features and feature median drift time. 
The micellar L16P PMP22 fingerprint shows two features, at 15.0 ± 0.3 ms and 23.5 ± 0.7 ms, and 
the bicellar L16P PMP22 fingerprints show three features, at 17.3 ± 0.4 ms, 21.4 ± 0.2 ms, and 
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25.5 ± 0.2 ms. These starting feature medians seem to contradict the CCS values above that show 
bicellar L16P PMP22 dimers to be more compact than micellar L16P PMP22 dimers. However, 
as CCS analysis calibrates for day-to-day instrumental variations in arrival time distributions, it is 
likely the more accurate depiction of the relative starting compactness and we therefore conclude 
that bicellar L16P PMP22 dimers are more compact that micellar L16P PMP22 dimers.    
It is interesting to note that the difference between the first and second feature in micellar 
L16P PMP22 dimers (8.5 ms) is very similar to the difference between the first and last feature of 
bicellar L16P PMP22 dimers (8.27 ms). Additionally, the CIU50 of the micellar transition (28.9 
V) is very similar to the midpoint between the two transitions of 18.3 ± 1.0 V and 38.6 ± 0.8 V 
(28.4 V). This could be evidence that the bicellar unfolding trajectory possesses similar starting 
and ending conformations to the micellar protein, but also experiences an intermediate phase 
which either does not exist or is short lived in terms of voltage space for the micellar protein. This 
intermediate phase would presumably occur in the voltage space between features one and two of 
the L16P PMP22 micellar fingerprints, in which the centroids are not flat enough to detect a 
Figure 5-3. CIU of L16P PMP22 dimeric complexes liberated from detergent micelles and SCOR bicelles. All fingerprints shown 
are for the 13+ dimeric charge state. A. Feature detection analysis of L16P PMP22 dimers liberated from C12E8 micelles, N = 3, 
shows two features of 15.0 ± 0.3 ms and 23.5 ± 0.7 ms. CIU 50 transitions fit to these features occur at 28.9 ± 0.8 V. B. Feature 
detection analysis of L16P PMP22 dimers liberated from SCOR bicelles, N = 3, show three features of 17.3 ± 0.4 ms, 21.4 ± 0.2 
ms, and 25.5 ± 0.2 ms. CIU50 transitions fit to these features occur at 18.3 ± 0.9V and 38.6 ± 0.8 V. C. RMSD plot of the averaged 
bicellar replicate subtracted from the averaged micellar fingerprint for L16P PMP22 dimers shows an RMSD of 24.6%, which is 
almost 2x the replicate baseline RMSDs of 13.2% for L16P PMP22 dimers liberated from micelles and 4.5% for bicelles. 
 
Figure 5-4. CIU of WTtag PMP22 monomers liberated from detergent micelles, SCOR bicelles, and POPC nanodiscs. All 
fingerprints shown are for the 9+ monomeric charge state. A. Feature detection analysis of WTtag PMP22 monomers liberated from 
C12E8 micelles, N = 3, shows three features of 17.0 ± 0.2 ms, 19.9 ± 0.1 ms, and 21.7 ± 0.2 ms. CIU 50 transitions fit to these 
features occur at 27.8 ± 1.5 V and 41.2 ± 0.5 V B. Feature detection analysis of WTtag PMP22 monomers liberated from SCOR 
bicelles, N = 3, shows four features of 16.8 ± 0.2 ms, 19.8 ± 0.3 ms, 21.7 ± 0.2 ms, and  26.4 ± 0.2 ms. CIU 50 transitions fit to 
these features occur at 22.4 ± 1.3 V, 29.2 ± 2.0 V, and 62.8 ± 0.7 V. C. Feature detection analysis of WTtag PMP22 monomers 
lib rated from POPC nanodiscs, N = 3, shows three features of 20.0 ± 0.5 ms, 22.0 ± 0.3 ms, and 27.2 ± 0.2 ms. CIU 50 transitions
fit to these features occur at 27.8 ± 1.1 V and 44.7 ± 3.3 VFigure 5-5. CIU of L16P PMP22 dimeric complexes liberated from 
detergent micelles and SCOR bicelles. All fingerprints shown are for the 13+ dimeric charge state. A. Feature detection analysis of 
L16P PMP22 dimers liberated from C12E8 micelles, N = 3, shows two features of 15.0 ± 0.3 ms and 23.5 ± 0.7 ms. CIU 50 
transitions fit to these features occur at 28.9 ± 0.8 V. B. Feature detection analysis of L16P PMP22 dimers liberated from SCOR 
bicelles, N = 3, show three features of 17.3 ± 0.4 ms, 21.4 ± 0.2 ms, and 25.5 ± 0.2 ms. CIU50 transitions fit to these features occur 
at 18.3 ± 0.9V and 38.6 ± 0.8 V. C. RMSD plot of the averaged bicellar replicate subtracted from the averaged micellar fingerprint 
for L16P PMP22 dimers shows an RMSD of 24.6%, which is almost 2x the replicate baseline RMSDs of 13.2% for L16P PMP22 
dimers liberated from micelles and 4.5% for bicelles. 
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reliable feature. Regardless, the unfolding trajectories and starting gas phase structures are 
different enough that a direct stability comparison using the CIU50 data is not appropriate. These 
differences are highlighted in Figure 5-3C which shows the comprehensive difference analysis 
between micellar and bicellar L16P PMP22 dimer CIU fingerprints. As these homodimeric 
complexes were not previously reported before Chapter 3 of this thesis, further work in this system 
should focus on computational methods for generating dimeric structures to compare the CCS 
values found here. 
 
5.3.4 Comparison of CIU from PMP22 containing soluble construct liberated from micelles, 
bicelles, and nanodisc 
 Noting the marked differences between PMP22 dimers liberated from micelles and 
bicelles, we next aimed to compare PMP22 protein liberated from nanodiscs to our previous data 
sets. However, as shown in Figure 5-1 with TSPO monomers, it can be difficult to distinguish 
signals between the membrane scaffold protein, 22 kDa, and proteins of similar size such as the 
19 kDa PMP22. Additionally, we wanted to first begin with a monomeric system to compare across 
all three solubilization techniques to avoid the challenges we found in generating sufficient 
complex signal for CIU, as was the case with TSPO. For these reasons we chose to study a version 
of WT PMP22 which has an added 11 kDa of soluble tags, denoted throughout as WTtag PMP22. 
The WTtag PMP22 also proved more amenable to nanodisc sample preparation for nMS, as the 
penta-histidine tag included in the sequence allowed us to use a nickel affinity resin to separate 
incorporated nanodiscs from empty nanodiscs. Note that for this reason, the histag free construct 
of MSP1D1(-) was utilized, allowing specificity in Ni affinity resin step. 
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 As shown in Figure V-5, WTtag PMP22 can be successfully liberated and detected from 
C12E8 micelles, SCOR bicelles, and POPC MSP1D1(-) nanodiscs. Monomeric WTtag PMP22 is 
observed at charge states 7-15+ when solubilized in both micelles and bicelles, but the WTtag 
PMP22 nanodisc IM-MS shows significant overlap with MSP1D1(-) signals in the higher m/z 
range, reducing the observable charge states to 7-12+ (Figure V-25C). At lower trap collision 
voltages, signals related to lipid bound MSP1D1(-) can also interfere with the WTtag PMP22 
signals. The 9+ charge state of WTtag PMP22 was found to be most suitable for CIU analysis due 
to its distance in mass to charge space from the MSP1D1(-) signals. CCS analysis of the 9+ charge 
Figure 5-10. CIU of WTtag PMP22 monomers liberated from detergent micelles, SCOR bicelles, and POPC nanodiscs. All 
fingerprints shown are for the 9+ monomeric charge state. A. Feature detection analysis of WTtag PMP22 monomers liberated 
from C12E8 micelles, N = 3, shows three features of 17.0 ± 0.2 ms, 19.9 ± 0.1 ms, and 21.7 ± 0.2 ms. CIU 50 transitions fit to 
these features occur at 27.8 ± 1.5 V and 41.2 ± 0.5 V B. Feature detection analysis of WTtag PMP22 monomers liberated from 
SCOR bicelles, N = 3, shows four features of 16.8 ± 0.2 ms, 19.8 ± 0.3 ms, 21.7 ± 0.2 ms, and  26.4 ± 0.2 ms. CIU 50 transitions 
fit to these features occur at 22.4 ± 1.3 V, 29.2 ± 2.0 V, and 62.8 ± 0.7 V. C. Feature detection analysis of WTtag PMP22 monomers 
liberated from POPC nanodiscs, N = 3, shows three features of 20.0 ± 0.5 ms, 22.0 ± 0.3 ms, and 27.2 ± 0.2 ms. CIU 50 transitions 
fit to these features occur at 27.8 ± 1.1 V and 44.7 ± 3.3 V 
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state for micelles and bicelles was found to yield similar values, at 2683 ± 12 Å2 and 2659 ± 12 Å2  
respectively. Contrastingly, the CCS for the 9+ charge state liberated from nanodiscs was found 
to be larger at 2793 ± 13 Å2. Given that the SCOR bicelles possess more biologically relevant 
lipids than the POPC nanodiscs, one could hypothesize that the protein should be more compact 
or folded when ejected from the bicelle. While we do observe the bicellar WTtag PMP22 monomer 
to be most compact in terms of CCS, there is no available high-resolution structure for the WTtag 
PMP22 construct to which we can compare our CCS values in order to assess their proximity to 
native folding. It is also interesting to note that while the L16P PMP22 data shows compaction of 
dimers liberated from the SCOR bicelles, the same trend is not observed here for WTtag PMP22 
monomers.   
 CIU fingerprints for the 9+ of WTtag PMP22 solubilized in the micelles, bicelles, and 
nanodiscs were generated in triplicate and their averages with detected features and CIU50 
transitions are shown in Figure 5-4. The WTtag PMP22 fingerprints from micelles and SCOR 
bicelles possess three similar features at approximately 17.0 ms, 19.9 ms, and 21.7 ms (Figure 5-
4 A, B). However, the most unfolded feature which occurs at 26.4 ms in the bicelle fingerprints is 
not detected in the micelle fingerprint, as it does not reach the necessary relative intensity within 
the bounds of the CV range. This information can be combined with the CIU50 values for the first 
and second transitions of the datasets to show that the WTtag PMP22 liberated from detergent 
micelles is more stabilized relative to SCOR bicelles. Interestingly, there are no apparent adduction 
differences in these data as there were for the CYP 3A4 data in Figure 5-2. To further explore the 
solubilization agent dependent changes in the CIU fingerprints of monomeric WTtag PMP22, 
comprehensive differences analysis was performed between all three datasets as shown in Figure 
V-6.  The micellar and bicellar fingerprints are found to be the most similar between the three 
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solubilization techniques, with an RMSD of 16.0%. This RMSD is still 3x the highest baseline 
replicate RMSD of 5.8%.  
 The features detected in the WTtag PMP22 nanodisc fingerprints are much different than 
those detected in the micellar and bicellar fingerprints, with features at 20.0 ± 0.5 ms, 22.0 ± 0.3 
ms, and 27.2 ± 0.2 ms (Figure 5-3C). The differences in starting CCS and starting features indicate 
that the WTtag PMP22 monomers liberated from POPC nanodiscs are beginning at a more unfolded 
state relative to the micelle and SCOR bicelles, and it is possible that the three features detected to 
for the nanodisc fingerprint correspond to the second, third, and fourth feature of the micellar and 
bicellar fingerprints. Comprehensive difference analysis also shows that the nanodisc fingerprints 
are significantly different from the micellar and bicellar fingerprints, with RMSDs of 25.4% and 
34.8% (Figure V-6), which are at least 2x greater than the nanodisc baseline replicate RMSD of 
16.0%. While there are clear differences between the unfolding trajectories  between all three 
solubilization techniques, more experiments would help elucidate the cause of these differences. 
For example, the addition of WTtag PMP22 liberated from POPC bicelles or nanodiscs with more 
complex lipid mixtures could allow for the independent analysis of the lipid composition effect 
from the solubilization technique and vice versa. Further, the partly soluble protein construct, CYP 
3A4, presented here would be an interesting comparison point for another full data set with 
micelles, bicelles, and nanodiscs of a mostly hydrophobic transmembrane protein, such as TSPO 
or PMP22 without soluble tags.  
   
5.4 Conclusions 
NMS methods have been extended to membrane proteins solubilized using many 
solubilization techniques, and here we have demonstrated that IM-MS and CIU methods can also 
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be extended from detergent micelles to more complex membrane mimetics. We show that IM-MS 
can inform nanodisc optimization protocols pertaining to protein complexes using TSPO as a 
model system. We report CIU fingerprints from SCOR bicelles and nanodiscs for multiple proteins 
which are readily analyzed by existing software workflows. In the case of CYP 3A4, we observe 
excess detergent, salt, and glycerol adduction cause increased stability of micellar samples relative 
to nanodisc samples. We show that these methods can be used to study protein complexes with 
L16P PMP22 and find preliminary evidence that SCOR bicelles may support more compact gas 
phase dimers than C12E8 micelles. Additionally, we find that for WTtag PMP22, CIU fingerprints 
from three different solubilization techniques exhibit differences which are not explained by the 
presence of lipids alone. However, from our data we cannot determine whether the differences are 
a function of the lipid composition, SCOR mixed lipids versus POPC, or the solubilization 
methods used. 
 Overall, we find that CIU is sensitive to the solubilization technique a protein is housed 
in, as all CIU fingerprints gathered here for the same protein, PMP22, liberated from different 
solubilization techniques were different to some extent. To further this area of research, studies to 
parse out of the contribution of lipid composition to the unfolding trajectories will be key, as our 
current data cannot rule out the possibility that a protein liberated from a POPC bicelles and POPC 
nanodisc do not present the same CIU fingerprint. Additionally, extension to more diverse protein 
systems, such as GPCRs, could be vital for defining the role of membrane protein nMS in the 
assessment of solubilization agents for applications such as cryo-EM or pharmaceutical screens.  
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Chapter 6 Conclusions and Future Directions 
6.1 Conclusions 
 Due to their important roles in cells, many disease states can be linked to the dysfunction 
of membrane proteins and the majority of pharmaceuticals approved by the FDA target membrane 
proteins. Dynamic structural measurements of membrane proteins can help elucidate the role of 
these proteins in disease and how pharmaceutical interventions can be designed to treat them. 
However, the challenges associated with their hydrophobic nature and complex native 
environments has severely limited the biophysical characterization of membrane proteins. This 
thesis adds important workflows and analysis methods to the growing field of membrane protein 
mass spectrometry aimed at overcoming the challenges associated with membrane protein 
characterization. Specifically, the comparative stability analyses and classification workflows 
presented in this thesis demonstrate novel ways to study the effects of mutation, disease 
association, and ligand binding on gas phase membrane protein structure, which could be broadly 
applied to membrane proteins beyond those described in this work.  
 One hinderance to the broader adoption of CIU techniques for membrane proteins is the 
large amount of noise which can be generated by solubilization agents. In Chapter 2, we 
demonstrate a workflow for removing this noise from CIU fingerprints using Gaussian fitting and 
automated feature detection, and we use this workflow to screen lipid and protoporphyrin binding 
to a protein of therapeutic interest, TSPO. We further extend our method to characterize the CIU 
of a previously unidentified endogenous lipid bound to TSPO. Through the use of CIU 
classification schemes, stability analysis, and high-resolution MS (HRMS), we are able to identify 
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the endogenous lipid as a set of lipids containing the PG head group with various chain lengths 
and saturations. As the observance of endogenously bound lipids is common in membrane protein 
MS, this workflow for identifying endogenous lipids through CIU and HRMS contributes to the 
larger field of membrane protein MS. Our identification of the endogenous lipids as PG with 
varying chain length is supported by recently published tandem HRMS workflows, in which lipids 
ejected from native TSPO dimers were fragmented to yield detailed head group and chain length 
distributions.194 Further, the denoising workflow presented in this chapter can be utilized to 
manage noise related issues in CIU datasets from any protein origin. 
 There are multiple membrane proteins for which sequence mutations can cause pathogenic 
misfolding and the stability of these mutant protein variants has been implicated in disease 
etiology.  While much progress has been made using CIU to characterize membrane protein ligand 
binding, no studies have previously attempted to detect CIU differences in membrane proteins 
based on their sequence associated disease pathology. In Chapter 3 and 4, we demonstrate the 
ability of IM-MS and CIU to detect differences in sequence variants of two disease associated 
membrane proteins, PMP22 and KCNQ1 VSD. We show that sequence variants of PMP22 can 
exhibit altered stability and dimeric complex formation, and that differences in dimeric complex 
formation are intensified when the protein is liberated from SCOR bicelles, which mimic the 
proteins native lipid environment. Our data adds key pieces of information to previously published 
cellular biology assays and allows us to construct a mechanism of PMP22 disregulation leading to 
neuropathic disease. For KCNQ1 VSD, we build a classification scheme capable of differentiating 
variants based on disease association and set up a framework for rapidly evaluating the hundreds 
of disease-associated protein variants. We also find preliminary evidence of destabilization of the 
KCNQ1 VSD variant R231C, which has been shown to exhibit unique cellular trafficking and 
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expression properties. Together, these chapters add to the knowledgebase of each respective 
protein and lay the groundwork for extension to high-throughput screens of protein variants in 
misfolding diseases.   
 Finally, as all CIU of membrane proteins reported to date have used detergent micelles as 
solubilization agents, we endeavored to assess the utility and compatibility of CIU with proteins 
liberated from more complex membrane mimetics. We show that different membrane mimetics 
present different noise related challenges, and that IM-MS can be used to inform nanodisc 
incorporation protocol optimization for protein complexes. We also present the first CIU of 
membrane proteins liberated from bicelles and nanodiscs in multiple protein systems. We find that 
CIU is sensitive to the solubilization agent used for each membrane protein and describe the 
importance of this data in the context of membrane protein solubilization agent screening.  
 Overall, this thesis presents multiple workflows related to denoising, membrane protein 
classification, and stability analysis which can be adopted by the growing field of membrane 
protein MS. Throughout our experiments, we have also added valuable information to the fields 
of membrane protein misfolding diseases, endogenous lipid binding, and mimetic incorporation 
protocols. 
 
6.2 Future Directions 
 
6.2.1 High-throughput membrane proteins screens 
 At odds with the intrinsic challenging nature of membrane proteins are the many types of 
information which could be valuable to their characterization. Screens of small molecule binding 
to membrane proteins, stability and disease association of the hundreds of known protein variants 
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in membrane protein misfolding diseases, and lipid screening of membrane proteins to illuminate 
biological interactions can all be imagined to add a dearth of information to our understanding of 
membrane protein interactions and roles in disease. In this thesis, we have presented workflows 
which demonstrate the capability of obtaining the information content that is garnered by each of 
those screens. The experiments detailed here have been relatively low throughput due to 
limitations in manual sample handling, with each experiment requiring a few hours of sample 
preparation before the data can be collected. The use of automated sample handling methods 
interfaced to the mass spectrometer would greatly increase the throughput of experiments, where 
one can imagine many samples are prepared in tandem by researchers and then stored in well 
plates for automated injection and analysis. Additionally, software advances now allow for batch 
processing of CIU data with the denoising processes described in this thesis, which could allow 
for even shorter data collection times on the scale of seconds per instrument voltage scanned. 
The demonstration of a high throughput membrane protein screens based on native IM-MS and 
CIU could enable the adoption of these technologies as routine analyses in research and industry.  
   
6.2.2 CIU of membrane proteins from diverse solubilization methods 
The utility of detergent micelle-based solubilization agents for native mass spectrometry 
(nMS) of membrane proteins has been thoroughly demonstrated in this thesis and work by others. 
However, as micelles do not form bilayers similar to the membranes in which these proteins 
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natively reside, their wide use and the 
biological conclusions drawn from proteins 
solubilized in micelles use has been, 
rightfully, called into question.  However, as 
the field moves to embrace lipid-based 
membrane mimetics, we ask if an artificial 
bilayer formed of only one lipid is any 
“better” at mimicking the native folding and 
structure of a membrane protein? Similarly, 
how does the ability to preserve structure 
change when bilayers are formed with a 
complex mixture of lipids that are 
constrained by an artificial boundary 
provided by membrane scaffold proteins or detergents in nanodiscs and bicelles? These questions 
are difficult to address and remain largely unanswered. We see nMS and CIU as uniquely suited 
to explore these questions and inform on the practical use of each of these solubilization methods. 
In this thesis we have begun to address these questions and demonstrated that CIU is indeed 
sensitive to the solubilization method of membrane proteins, but we assert that a more 
comprehensive analysis of lipid composition and solubilization method for a diverse set of 
membrane proteins would greatly aid to the development of this field. 
 
Figure 6-1. Example of optimized solubilization agents across 
different mimetics. Both lipid composition and mimetic type are 
optimized to result in the most compact gas phase structure. 
 
Figure 6-2. Example of optimized solubilization agents across 
different mimetics. Both lipid composition and mimetic type are 
optimized to result in the most compact gas phase structure. 
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Appendices  
 
I. Chapter 2 Supporting Information 
 
 
Expected Observed 
TSPO dimer 35.952 36.033 
TSPO monomer 17.976 17.964 
TSPO:Ligand Complexes Mass Analysis (in kDa) 
 Exp Obs Exp Obs Exp Obs Exp Obs Exp Obs 
1 Bound 2 Bound 3 Bound 4 Bound 5 Bound 
TSPO: 14:0 
CDL 
37.296 37.316 38.558 38.557 39.821 39.812 - - - - 
TSPO: 18:1 
PA 
36.733 36.762 37.433 37.477 38.133 38.183 - - - - 
TSPO: 18:1 
PE 
36.777 36.843 37.521 37.559 - - - - - - 
TSPO: 16:0 
PI 
36.841 36.911 37.649 37.729 - - - - - - 
TSPO: 16:0-
18:1 PS 
36.794 36.819 37.555 37.587 38.316 38.349 39.077 39.131 39.838 39.888 
TSPO: 16:0-
18:1 PC 
36.793 36.822 37.553 37.558 38.313 38.321 - - - - 
TSPO: 16:0 
PG 
36.778 36.771 37.523 37.506 38.268 38.244 39.013 39.013 - - 
TSPO: 
Endogenous 
Ligand - 36.806 - 37.478 - - - - - - 
TSPO: PPIX 36.596 36.683 37.158 37.235 - - - - - - 
 
Figure I-1 . Mass Analysis of TSPO and TSPO Ligand Complexes. Expected (Exp) and 
observed (Obs) are listed for all complexes used in analysis (kDa) and the small 
differences shown are attributed to the nature of native mass spectrometry 
experiments. Expected TSPO:ligand complex masses were calculated by adding 
the ligand weight to the value listed in the observed TSPO dimer mass (36.033 
kDa). Note that when ligands are added to the solution, the peak corresponding to 
the TSPO dimer alone tends to increase in mass slightly, indicating increased 
adduction. This increased mass was used to measure the weight of the endogenous 
ligand across replicates (740 ± 20 m/z). 
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Figure I-2 Detergent screen of TSPO. All IM-MS data shown in squared scale. Peaks labeled 
with black lettering are consistent with masses expected for TSPO monomer or 
dimer. Peaks labelled with red lettering are not consistent with TSPO complexes 
and are most likely detergent signals. A. IM-MS of TSPO solubilized in OG (Octyl 
β-D-glucopyranoside) shows dimer (blue triangles) at multiple charge states, 
including the 9+. B-E. Other detergents screened include Cymal-5 (5-Cyclohexyl-
1-Pentyl-β-D-Maltoside), C12E8 (Dodecyl Octaethylene Glycol Ether), NG (n-
Nonyl-β-D-Glucopyranoside), and OM (n-Octyl-β-D-Maltopyranoside). C12E8 
and NG datasets showed no signals corresponding to TSPO monomer or dimer, 
while OM showed only low-intensity monomer signals that appear to be non-
native. Cymal-5 IM-MS does show TSPO dimer, but heavy adduction is present 
even at high energies. Additionally, the Cymal-5 data show highly charged 
monomer signals, indicative of non-native folding. Due to these factors, OG was 
chosen as the ideal detergent over Cymal-5. 
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Figure I-3 Width analysis for Gaussian denoising. The arrival time for the apo 9+ TSPO dimer 
can be extracted without interfering micellular noise at the lowest collision voltage 
energies. From this data, a Gaussian distribution was fitted and the full width at 
half maximum can be measured. These measurements (3ms) and a manually 
optimized tolerance of (0.4 ms) were used as parameters in Gaussian fitting of full 
CIU fingerprints using CIUSuite 2.1, and in combination with relative peak 
intensity was used to differentiate noise signals from TSPO signals, where noise 
signals were over 3ms in width and lower intensity. 
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Figure I-4 Feature detection of Gaussian fitted CIU data. Gaussian centroids are originally 
assigned as corresponding to either protein (blue) or noise- related signals (red). 
These assignments are all automated and are a function of the input parameters 
from Figure I-3. Feature detection is performed on these Gaussian peaks to obtain 
Figure 2-2E and this reduced data set is used for all CIU50 and classification 
analysis. The feature detection parameters of feature length and tolerance were 
manually optimized for each ligand set to obtain fits which most accurately 
reflected the fingerprint, and automated re-assignments as noise or protein were 
made after feature detection. Highlighted by letters a-d in this figure are the four 
possible outcomes for centroids after automated feature detection is performed. a. 
These Gaussian centroids assigned as TSPO signals combine to form a feature, 
defined by the following input parameters: feature length (10 steps), allowed width 
(1 ms), and minimum collision voltage step gap (2 steps). b. These centroids 
assigned as noise signals are not incorporated in any features and are excluded from 
the final dataset. c. This centroid was assigned as a TSPO related signal during 
Gaussian fitting but is excluded from the final de-noised dataset as it is not part of 
a feature. d. This centroid originally assigned as a noise signal is re-assigned as a 
protein related peak due to its good agreement with surrounding TSPO peaks which 
form a feature. 
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Figure I-5 Mass spectra of ligand bound TSPO. After incubation with the selected ligand 
(except in the case of the endogenous ligand), dimer TSPO can be observed in 
complex with 2-5 ligands at charge states 8-10+. The 9+ charge state mainly used 
in our analysis is labeled in blue. For clarity of peak assignment, these spectra were 
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taken at high voltages and baseline corrected in MassLynx. A. 1',3'-bis[1,2-
dimyristoyl-sn-glycero-3-phospho]-glycerol [14:0 CDL].  B. 1,2-dioleoyl-sn-
glycero-3-phosphate[18:1 PA]. C. 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine [18:1 (Δ9-Cis) PE]. D. 1,2-dipalmitoyl-sn-glycero-3-
phospho-(1'-myo-inositol)[16:0 PI].  E. 1-palmitoyl-2-oleoyl-sn-glycero-3-
phospho-L-serine [16:0-18:1 PS]. F. Protoporphyrin IX (PPIX). G. 1,2-
dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol) [16:0 PG]. H. A previously 
unknown endogenous ligand, proposed in this manuscript to be a group of lipids 
possessing the PG head group.  I. 1-palmitoyl-2-oleoyl-glycero-3-phosphocholine 
[16:0-18:1 PC] 
  96 
 
Figure I-6 CIU fingerprints of TSPO:ligand complexes. Averaged fingerprints, n=3, of the 
one ligand bound state for each ligand. Fingerprints were collected in 5 V 
increments from 50 -140 V, with each increment comprising scans averaged over 
2 minutes. Above 140 V, signal quality was severely degraded and no additional 
unfolding was able to be observed. Ligand binding causes some differences that 
are observable by eye, such as stabilization of the first and second features by 
ligands PPIX, PG, UNK, as well as the unique unfolding pathway of the lipid PC. 
In all PC replicates, it seems that the most unfolded state occurs at lower voltages 
than Apo TSPO, indicating destabilization. 
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Figure I-7 HRMS of lipid extraction from TSPO with endogenous lipid present. Each labeled 
peak from positive and negative mode electrospray was isolated and fragmented at 
varying HCD energies. Intact mass and fragment masses were considered when 
using LipidMaps to attempt to identify peaks. Lipid matches were identified for 
peaks labeled with blue, and exact lipid chain information was obtained for all 
except those marked with (*). Orange labeled peaks yielded no lipid identification 
information. 
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Figure I-8 Classification of TSPO complexes by lipid head group charge. A. Each voltage 
was scored for the ability to differentiate three classes: neutral lipids (PC, PE), 
lipids with a net charge of -1 (PA, PG, PI, PS) and lipids with a net charge of -2 
(CDL), N = 3 for each ligand. Voltages in the gray box were selected for cross-
validation,  inset plot, and one voltage (*) was chosen to build the scheme based on 
accuracy. B. Three-way classification depicted as decision regions on linear 
discriminant axes shows that some neutral replicates were classified as negatively 
charged, indicating that the scheme built is not capable of reliably classifying 
TSPO:lipid complexes based on head group charge. Attempts to manually identify 
voltage combinations that may yield better separation gave similar or worse results, 
where neutral lipids were often misclassified as negative (data not shown). C. Three 
replicates that often classified incorrectly corresponded to the neutral lipid PE, 
where the classification scheme grouped PE with the -1 charge lipids (PA, PI, PG, 
PS). Looking at the features detected for PC, PE, and PA, it is clear that PE and PA 
fingerprints possess very similar features. Although the typical physiological 
charge of DOPE and DOPA is different, their shared attribute of chain unsaturation 
(2 double bonds) can be used effectively to classify these fingerprints. (Figure 2-
5).
  99 
II. Chapter 3 Supporting Information 
 
Figure II-1  Mass Analysis of PMP22 Variant Monomers and Dimers. Expected (Exp) and 
observed (Obs) are listed for all complexes used in analysis (Da). Note that due to 
the presence of two extra amino acid residues related to variations in thrombin 
cleavage, the signals corresponding to the lowest mass to charge at each charge 
state were chosen for mass analysis. More information on the additions can be 
found in Figure II-4. 
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Figure II-2 Sequence location of PMP22 mutations studied in this work. In addition to WT 
PMP22, two mutations associated with the mild neuropathy HNPP (A67T and 
S22F), two mutations associated with the moderate neuropathy CMT1 (T118M and 
G93R), and three mutations associated with the severe neuropathy DSS (L16P, 
H12Q, and G150D) were characterized in this work.   
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Figure II-3 Mass spectra of PMP22 variants released from C12E8 detergent micelles. For all 
variants released from detergent micelles, charge states associated with monomer 
(green) and dimer (blue) were observed. Based on the charge states envelope, some 
signals were determined to contain indistinguishable amounts of both monomer 
and dimer (gray). These signals were excluded from percent dimer calculations. 
Spectra shown here are background subtracted for visualization purposes, but data 
de-noising for further analysis is only performed as described in Figure II-8. 
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Figure II-4 HRMS identifies thrombin cleavage related additions to PMP22. PMP22 S22F 
without any additions can be observed at the major peak of 1934.53 Th. PMP22 
S22F with an additional two residues, proline and arginine, can be observed at the 
minor peak of 1954.24 Th. The presence of the additional residues is likely a result 
of promiscuous cleavage at the thrombin cleavage site. Present in all micelle 
samples except G150D, which were prepared using thrombin from a different 
company. CIU of data extracted with narrow windows from each individual amino 
acid addition exhibited no significant differences, so to maximize signal intensity, 
all CIU include the base protein and additions. 
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Figure II-5 9+ monomer and 13+ dimer CIU fingerprints for all variants studied in this work. 
Averaged, N=3. A. Automated CIU feature detection (left) and CIU50 sigmoidal 
transitions (right) for monomeric PMP22 reveal that all PMP22 mutations except 
for S22F show some degree of destabilization relative to WT. B Automated CIU 
feature detection (left) and CIU50 sigmoidal transitions (right) for dimeric PMP22 
reveal that all PMP22 mutants are stabilized relative to WT.    
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Figure II-6 Correlative plots. Nerve conduction velocities (NCV), cellular trafficking 
efficiencies, and ΔΔGapp,total from Schlebach et al. 2015. A, B. NCVs (m/s) versus 
monomeric PMP22 CIU50 transition values (V) and percent dimer. Linear 
regression analysis of NCV versus CIU50 yields R2 = 0.57. No significant 
relationship between NCV and percent dimer is observed.  C. Monomer CIU50 
transition (V) versus percent dimer shows a linear inverse correlation with R2 = 
0.46 when all data are included. *When the WT PMP22 data point is removed from 
this data R2 = 0.61. D,E. ΔΔGapp,total (kcal/mol) versus monomer CIU50 transition 
(V) and percent dimer show no significant correlations. **ΔΔGapp,total is a measure 
of Zn(II) binding free energy associated with protein folding. F. Percent dimer 
versus trafficking efficiency. An exponential fit yields R2 = 0.66. 
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Figure II-7 Mass spectra of G150D PMP22 released from SCOR bicelles. Signals 
corresponding to monomer (green), dimer (blue) and mixed monomer and dimer 
signals (gray) are observed. 
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Figure II-8 Denoising of bicelle and G150D micelle data. A, B, C. Mass to charge versus 
arrival time plots of PMP22 variants liberated from SCOR bicelles exhibited noise 
signals associated with lipid and detergent clusters in the lower arrival time and 
mass to charge space. To minimize any bias towards monomeric PMP22 in the 
percent dimer analysis, the data extract was parameterized to extract only the 
arrival time distribution starting at 18 ms. D. G150D micelle samples were prepared 
and stored in glycerol, which led to a similar clustering issue in the low mass to 
charge range. G150D micelle arrival time distribution data was extracted starting 
at 17 ms. Note, this noise was not present in other micelle samples as there was no 
glycerol present, so no de-noising was performed. 
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III. Chapter 3 Supporting Methods 
 Preparation of SCOR bicelles: The sphingolipid and cholesterol-rich (SCOR) bicelle used 
in this study is composed of a lipid mixture consisting of 1,2-dimyristoyl-sn-glycero-3-
phosphocholine (DMPC), egg sphingomyelin (eSM), and cholesterol in a mole ratio of 4:2:1, and 
the detergent  -n-dodecylmelibioside (DDMB), such that the q ratio (lipid-to-detergent mole 
ratio) is 0.33. Powdered samples of DMPC (CardenPharma), egg SM (NOF Corporation), and 
cholesterol (Sigma-Aldrich) necessary to make a 10-mL stock solution of 6% (w/v) SCOR bicelles 
were first weighed out into a 15-mL glass vial and the mixture was dissolved in chloroform by 
vortexing. The solvent was then evaporated at 45 °C in a Smart Evaporator C1 (BioChromato) 
until a gel-like substance remained. The lipid mixture was then lyophilized overnight to remove 
the remaining solvent. The lyophilized mixture was resuspended in 15% (w/v) stock solution of 
DDMB (Anatrace) in milliQ water at a volume necessary to bring the q ratio to 0.33. The volume 
of the mixture was brought to 10 mL by adding milliQ water. The resulting mixture was then 
subjected to a series of freeze-thaw cycles consisting of freezing in liquid nitrogen, followed by 
thawing in warm sonication bath, and extensive vortexing before freezing again, until it turned 
clear (usually at least three cycles). The formation of SCOR bicelle was confirmed by dynamic 
light scattering. 
 Expression of PMP22: Wild type and mutant PMP22 (i.e S22F, A67T, T118M, G93R, 
L16P and H12Q) proteins were expressed in E. coli BL21(DE3) as described.1  Briefly, the 
plasmid containing cDNA encoding recombinant human PMP22 was transformed in the E. coli 
BL21 star (DE3) cells and grown in minimal M9 media at 20 °C with agitation. 1 mM Isopropyl 
β-D-1-thiogalactopyranoside (IPTG) was added when OD600 was ~0.8, to induce the expression 
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of the PMP22 protein. Cells were harvested by centrifugation ~22 hours after induction and the 
cell pellets were flash frozen until use in purification. 
 Purification of human PMP22 in detergent micelles: Recombinant PMP22 proteins (i.e. 
WT, S22F, A67T, T118M, G93R, L16P and H12Q) were purified on Ni-NTA column (Qiagen) 
as described1 with some modifications. To refold the protein, the EMPIGEN BB detergent (N,N-
Dimethyl-N-dodecylglycine betaine, N-(Alkyl C10-C16)-N,N-dimethylglycine betaine, Sigma-
Aldrich) was exchanged with Decyl-Maltoside (DM, Anatrace) by rinsing PMP22 bound to Ni-
NTA resin with 200 ml of 50 mM Tris buffer (pH 8.0) contained 0.5% DM and 1mM TCEP 
(Tris(2-carboxyethyl)phosphine, COMPANY). PMP22 and PMP22 mutants were eluted with 300 
mM Imidazole dissolved in refolding buffer (5mM Imidazole, 50mM Tris buffer pH 8.0, 0.15% 
DM and 1mM TCEP). Finally, after overnight thrombin cleavage the 50 ml protein solution was 
passed over a second Ni-NTA column that was pre-equilibrated with 50mM Tris buffer (pH 8.0) 
containing 0.15% DM and 1mM TCEP. Flow through was discarded and bound PMP22 was eluted 
with 15 mM Imidazole dissolved in 50mM Tris buffer pH 8.0, 0.15% DM and 1mM TCEP. The 
PMP22 proteins were concentrated to 1-2 mg/ml and stored at -80°C for use in mass spectrometry 
studies. The final protein concentration was estimated by measuring the absorbance at 280 using 
an extinction coefficient of 44,900 M−1cm−1. 
 Purification of PMP22 into SCOR Bicelles: Cells containing overexpressed PMP22 were 
resuspended in lysis buffer (75 mM Tris-HCl (pH 7.5), 300 mM NaCl, 0.2 mM EDTA) at 20 mL 
buffer per gram of cell pellet. Lysozyme (0.2 mg/mL), DNase (0.02 mg/mL), RNase (0.02 
mg/mL), phenylmethanesulfonyl fluoride (PMSF, 1 mM), and magnesium acetate (5 mM) were 
added and the mixture was tumbled for at least 30 minutes at 4 °C, followed by probe-sonication 
on ice for 10 minutes. To dissolve the protein from the membrane and inclusion bodies, lauryl 
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betaine (empigen detergent, BOC Sciences) to a final concentration of 3%, as well as glycerol 
(15%) and tris(2-carboxyethyl)phosphine (TCEP, 1 mM), were added, and the mixture was rotated 
at 4 C for at least an hour. The insoluble cell debris were then removed by centrifugation of the 
lysate at 20,000 rpm and 4 C for 30 minutes. The supernatant was collected and mixed with 0.5 
mL of pre-equilibrated HisPurTM Ni-NTA Superflow Agarose resin (Thermo Scientific) per gram 
of cell pellet. The resulting mixture was rotated at 4 °C for ~14 hours. 
 The resin was then packed into a chromatography column and washed first with 5 column 
volumes (CV) of purification buffer (40 mM HEPES (pH 7.5), 300 mM NaCl) containing 15% 
glycerol, 3% empigen, and 1 mM TCEP, followed by purification buffer containing 40 mM 
imidazole, 15% glycerol, 1.5% empigen, and 1 mM TCEP, until the measured absorbance at 280 
nm reaches the baseline, indicating elution of weakly bound impurities (typically ~15 CV). The 
empigen detergent was then exchanged with n-tetradecylphosphocholine (TDPC, Anatrace) by 
washing the resin with 12 CV of 25 mM sodium phosphate buffer (pH 7.2) containing 0.2% TDPC 
and 1 mM TCEP. The PMP22 fusion protein was then eluted from the resin using 50 mM Tris 
buffer (pH 8) containing 500 mM imidazole, 0.2% TDPC and 1 mM TCEP. 
 The eluted protein was buffer exchanged twice with 20 mM sodium dihydrogen phosphate 
buffer (pH 7.5) containing 1 mM TCEP to get rid of the imidazole. Each buffer exchange cycle 
consisted of concentrating the solution to ~1 mL by centrifugation at 3,000 x g using a 10K MWCO 
Amicon Ultra-15 centrifugal filter device (Millipore) and diluting back to ~15 mL. The final 
solution was then concentrated to ~5 mL before loading into a pre-equilibrated HiTrap SP FF 
cation exchange column (GE Healthcare) for cation exchange chromatography. The cation 
exchange chromatography serves two purposes: to remove a common E. coli stress protein YodA 
that cooverexpressed and coeluted with the PMP22 fusion protein, and to replace the membrane 
  110 
mimetic from TDPC to SCOR bicelles. After loading the sample, the column was then washed 
with at least 30 CV of 20 mM sodium dihydrogen phosphate buffer (pH 7.5) containing 1 mM 
DTT, 0.2% SCOR bicelle (q = 0.33), and 0.3 mM β-n-dodecylmelibioside (DDMB, Anatrace) to 
exchange the membrane mimetic. The PMP22 fusion protein in SCOR bicelles was eluted by 
running a gradient where the concentration of NaCl is increased from 0 to 1 M over the course of 
14 CV. 
 Cleavage of the fusion partner of PMP22 was carried out by adding 1000 units of thrombin 
(Recothrom) to ~0.8 mg/mL of purified PMP22 fusion protein adjusted to pH 8.0 by addition of 
20 mM Tris buffer (pH 8.0) prior to cleavage. The solution was rotated gently at room temperature 
overnight. The His tag-containing fusion partner, as well as uncleaved PMP22 fusion protein, were 
separated from the cleaved PMP22 by performing another Ni affinity chromatography. Pre-
equilibrated Ni-NTA resin (at 1 mL per 10 mg fusion protein) and 20 mM imidazole were added 
to the cleavage reaction mixture before rotating for at least an hour at 4 C. The resin was packed 
into a chromatography column and the flow through containing most of the cleaved PMP22 was 
collected. Successive washes with 20 mM Tris buffer (pH 8.0) containing 0.2% SCOR bicelle (q 
= 0.33), 0.3 mM DDMB, 1 mM TCEP, and increasing concentrations of imidazole (20 mM, 30 
mM, 40 mM, 250 mM) were carried out. The solution containing the cleaved PMP22 was 
concentrated before loading into a pre-equilibrated size exclusion column (GE Superdex 200 
Increase 10/300 GL). Size exclusion chromatography was performed using 10 mM acetate buffer 
(pH 5.0) containing 100 mM NaCl, 0.2 % SCOR bicelle (q = 0.33), 1 mM EDTA, 5 mM TCEP, 
and 0.3 mM DDMB to remove empty bicelles and to exchange the buffer. Fractions containing 
PMP22 were combined and concentrated using 10K MWCO Amicon concentrator for use in native 
ion mobility-mass spectrometry experiments. The final concentration of PMP22 in SCOR bicelles 
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was determined by measuring the absorbance at 280 nm using an extinction coefficient of 41,940 
M-1 cm-1. 
  
  112 
IV. Chapter 4 Supporting Information 
Masses of KCNQ1 VSD (Da) 
 
Expected Observed 
 
Monomer 
KCNQ1 VSD WT 18158 18208 
KCNQ1 VSD R231C 18086 18152 
KCNQ1 VSD E115G 18105 18131 
KCNQ1 VSD H126L 18134 18181 
 
Figure IV-1 . Measured masses of KCNQ1 VSD variants. Expected and observed masses for 
KCNQ1 VSD WT, R231C, E115G, and H126L. As peak splitting related to single 
amino acid truncations was observed (~175 Da), these masses are calculated from 
the peak without truncation, which is also the most intense peak. 
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Figure IV-2 . Denoising of KCNQ1 fingerprints. Noise was noted in the low mass to charge 
and high voltage space, especially for mutant KCNQ1 forms which started at 
relatively lower concentrations before buffer and detergent exchange (top, 
averaged fingerprints N = 3). This noise was manually removed from each 
replicate’s text file to yield de-noised fingerprints, for which averaged examples 
are shown (bottom, N=3). 
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Figure IV-3 . Mass spectra of KCNQ1 variants. A-D. Mass spectra for KCNQ1 VSD WT, 
R231C, E115G, and H126L show the same charge state distribution of 5-10+ 
monomeric protein. Peak splitting of each charge state indicates a single amino acid 
truncation (~180 Da) for WT KCNQ1 VSD and possible additional amino acid 
truncations in the mutant species. CIU fingerprints generated with small extraction 
windows only encompassing individual truncations exhibited no significant 
differences, so the entire peak width was extracted for the CIU fingerprints shown 
in this work.  These spectra are post processed through background subtraction to 
add in visualization. 
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Figure IV-4 . Comprehensive difference plots for all KCNQ1 variants. A-F.  De-noised 
fingerprints were averaged, N = 3, for each KCNQ1 VSD form and comprehensive difference 
analysis was performed using CIUSuite 2.1 to yield an RMSD for each pairwise comparison. 
G. Summary of all RMSDs and baseline replicate RMSDs (thick border). 
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Figure IV-5 Trafficking and expression of KCNQ1 variants. Data collected by Hui Huang, 
Sanders lab at Vanderbilt University. The cell surface expression (A), total 
expression (B), and trafficking efficiency (C) of KCNQ1 mutants. HEK293 cells 
transiently expressing WT or mutant KCNQ1 were first treated with PE- 
conjugated antibody to stain surface KCNQ1 and then, following fixing and 
permeabilization, with Alexa Fluor 647-conjugated antibody to stain intracellular 
KCNQ1. Values are given as % of WT after correction for nonspecific staining. 
Mutant trafficking efficiency %WT=[mutant surface/mutant total]/[WT 
surface/WT total]*100. Results are expressed as mean ± S.E.M. of at least three 
independent experiments. *Significantly different from WT KCNQ1, P<0.05. 
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V. Chapter 5 Supporting Information 
Measured Masses 
 Expected Observed Expected Observed 
 Monomer Dimer 
A138F TSPO (Micelle) 17976 18005 35952 36033 
A138F TSPO (Nanodisc) 17976 17994 35952 36008 
CYP 3A4 - holo (Micelle) 57561 57783 - - 
CYP 3A4 - holo (Nanodisc) 57561 57588 - - 
PMP22 L16P (Micelle) 19260 19265 38520 38800 
PMP22 L16P (Bicelle) 19260 19480 38520 38998 
PMP22 WT with tag (Micelle) 30353 30214 - - 
PMP22 WT with tag (Bicelle) 30353 30237 - - 
PMP22 WT with tag (Nanodisc) 30353 30304 - - 
 
Figure V-1 . Expected and observed masses for all protein forms studied in Chapter 5. 
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Figure V-2 IM-MS datasets of TSPO liberated from various solubilization conditions. A. Example 
data of TSPO liberated from OG micelles show intense signals related to dimeric 
complex. B,C,D. TSPO prepared in MSP1D1 nanodiscs with different lipid 
compositions of DMPC, DOPE, and DPPS. DMPC and DOPE IM-MS are shown at 
80V trap collision voltage and DPPS at 200V trap collision voltage as no protein could 
be observed at lower energies for that lipid composition. Only DOPE nanodiscs exhibit 
significant amounts of dimeric complex.  
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Figure V-3 Mass spectra and IM-MS datasets of CYP 3A4 liberated from micelles and nanodiscs. 
A. CYP 3A4 can be observed with the charge state distribution of 13-17+ when liberated 
from OG micelles. These peaks are broad enough that apo and holo protein forms cannot 
be resolved, however the centroid of the peak aligns well with weight for the holo CYP 
3A4. The peak broadness could be caused by detergent adduction. B. When liberated 
from nanodiscs, the apo, holo, and lipid bound peaks of CYP 3A4 can be resolved for 
the charge states 13-17+.  
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Figure V-4 . Mass spectra and IM-MS datasets of L16P PMP22 liberated from micelles and SCOR 
bicelles. A, B. When released from C12E8 micelles or SCOR bicelles, monomeric 
(green), dimeric (blue), and overlapping monomeric and dimeric (gray) charge states of 
L16P PMP22 can be detected. The 13+ dimeric charge state was chosen for CIU 
analysis.  
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Figure V-5 Mass spectra and IM-MS datasets of WTtag PMP22 liberated from micelles, SCOR 
bicelles, and POPC nanodiscs. A. When released from C12E8 micelles monomeric 
WTtag PMP22 can be observed from 7-15+, along with detergent related noise and a 
smaller contaminant protein. This contaminant could be related to degraded forms of 
the 11 kDa soluble tag, but we do not observe it to interact with the protein and the 
signals do not interfere with the 9+ charge state CIU. ted. The 9+ monomeric charge 
state was chosen for CIU analysis. B. When released from SCOR bicelles monomeric 
WTtag PMP22 can be observed from 7-15+, along with detergent and lipid related noise 
signals. C. When released from POPC nanodiscs, monomeric WTtag PMP22 can be 
observed from 7-12+, however any higher charge state overlaps significantly with 
MSP1D1 signals and cannot be distinguished. Some charge states can be separated in 
IM space from MSP1D1 although they possess significant mass to charge overlap. The 
9+ charge state is the most distant in mass to charge space from MSP1D1 signals and 
was chosen for CIU analysis.  
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Figure V-6 Comprehensive difference analysis of WTtag PMP22 9+ CIU fingerprints from C12E8 
micelles, SCOR bicelles, and POPC nanodiscs. Baselines replicate RMSDs are as 
follows: micelle 2%, bicelle 6%, nanodisc 16%. A. Bicelle subtracted from micelle, 
RMSD  = 16.0%. B. Bicelle subtracted from nanodisc, RMSD = 25.4%. C. Micelle 
subtracted from nanodisc, RMSD = 34.8%.  
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VI. Chapter 5 Supporting Methods 
Nanodisc incorporation protocol. Except for CYP 3A4 which was incorporated into POPC 
MSPE3D1(-) nanodiscs using a microfluidic device, all proteins were incorporated into nanodiscs 
using the protocol outlined by Sligar et al 2010.233  Successful incorporation conditions for TSPO 
and WTtag are as follows: For TSPO, the DOPE:MSP1D1(+histag):TSPO ratio was 65:4:1, which 
was incubated at DOPE Tm without TSPO for 30 minutes. The TSPO was added and incubated for 
additional 30 minutes before being added to detergent removal resin (Biobeads) and incubated for 
4 hours. Samples were prepared for nMS using 6 kDa or 40 kDa buffer exchange spin tubes. For 
WTtag PMP22: the POPC:MSP1D1(-): WTtag PMP22 ratio was 65:4:1 and the mixture was 
incubated on ice without WTtag PMP22 for 30 minutes. Then WTtag PMP22 and extra secondary 
detergent (DDM) were added to the mixture and incubated for additional 60 minutes. This was 
added to detergent removal resin (Amberlite XAD) and incubated at 6° C while shaking overnight. 
To remove empty nanodiscs, samples were then incubated with an equilibrated nickel affinity resin 
for 30 minutes and eluted with 1 mM imidazole. Size exclusion chromatography was performed 
on the eluent using a Superdex increase 10/300 gL prepacked Tricorn column equilibrated in 200 
mM ammonium acetate pH 7.4. Samples were concentrated using 10 kDa concentrators prior to 
nMS analysis. 
SCOR bicelles incorporation protocol. Cells containing overexpressed PMP22 were 
resuspended in lysis buffer (75 mM Tris-HCl (pH 7.5), 300 mM NaCl, 0.2 mM EDTA) at 20 mL 
buffer per gram of cell pellet. Lysozyme (0.2 mg/mL), DNase (0.02 mg/mL), RNase (0.02 
mg/mL), phenylmethanesulfonyl fluoride (PMSF, 1 mM), and magnesium acetate (5 mM) were 
added and the mixture was tumbled for at least 30 minutes at 4°C, followed by probe-sonication 
on ice for 10 minutes. To dissolve the protein from the membrane and inclusion bodies, lauryl 
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betaine (empigen detergent, BOC Sciences) to a final concentration of 3%, as well as glycerol 
(15%) and tris(2-carboxyethyl)phosphine (TCEP, 1 mM), were added, and the mixture was rotated 
at 4 C for at least an hour. The insoluble cell debris were then removed by centrifugation of the 
lysate at 20,000 rpm and 4°C for 30 minutes. The supernatant was collected and mixed with 0.5 
mL of pre-equilibrated HisPurTM Ni-NTA Superflow Agarose resin (Thermo Scientific) per gram 
of cell pellet. The resulting mixture was rotated at 4 °C for ~14 hours. 
 The resin was then packed into a chromatography column and washed first with 5 column 
volumes (CV) of purification buffer (40 mM HEPES (pH 7.5), 300 mM NaCl) containing 15% 
glycerol, 3% empigen, and 1 mM TCEP, followed by purification buffer containing 40 mM 
imidazole, 15% glycerol, 1.5% empigen, and 1 mM TCEP, until the measured absorbance at 280 
nm reaches the baseline, indicating elution of weakly bound impurities (typically ~15 CV). The 
empigen detergent was then exchanged with n-tetradecylphosphocholine (TDPC, Anatrace) by 
washing the resin with 12 CV of 25 mM sodium phosphate buffer (pH 7.2) containing 0.2% TDPC 
and 1 mM TCEP. The PMP22 fusion protein was then eluted from the resin using 50 mM Tris 
buffer (pH 8) containing 500 mM imidazole, 0.2% TDPC and 1 mM TCEP. 
 The eluted protein was buffer exchanged twice with 20 mM sodium dihydrogen phosphate 
buffer (pH 7.5) containing 1 mM TCEP to remove the imidazole. Each buffer exchange cycle 
consisted of concentrating the solution to ~1 mL by centrifugation at 3,000 x g using a 10 K 
MWCO Amicon Ultra-15 centrifugal filter device (Millipore) and diluting back to ~15 mL. The 
final solution was then concentrated to ~5 mL before loading into a pre-equilibrated HiTrap SP FF 
cation exchange column (GE Healthcare) for cation exchange chromatography. The cation 
exchange chromatography serves two purposes: to remove a common E. coli stress protein YodA 
that cooverexpressed and coeluted with the PMP22 fusion protein, and to replace the membrane 
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mimetic from TDPC to SCOR bicelles. After loading the sample, the column was then washed 
with at least 30 CV of 20 mM sodium dihydrogen phosphate buffer (pH 7.5) containing 1 mM 
DTT, 0.2% SCOR bicelle (q = 0.33), and 0.3 mM β-n-dodecylmelibioside (DDMB, Anatrace) to 
exchange the membrane mimetic. The PMP22 fusion protein in SCOR bicelles was eluted by 
running a gradient where the concentration of NaCl is increased from 0 to 1 M over the course of 
14 CV. 
 Cleavage of the fusion partner of PMP22 was carried out by adding 1000 units of thrombin 
(Recothrom) to ~0.8 mg/mL of purified PMP22 fusion protein adjusted to pH 8.0 by addition of 
20 mM Tris buffer (pH 8.0) prior to cleavage. The solution was rotated gently at room temperature 
overnight. The His tag-containing fusion partner, as well as uncleaved PMP22 fusion protein, were 
separated from the cleaved PMP22 by performing another Ni affinity chromatography. Pre-
equilibrated Ni-NTA resin (at 1 mL per 10 mg fusion protein) and 20 mM imidazole were added 
to the cleavage reaction mixture before rotating for at least an hour at 4 °C. The resin was packed 
into a chromatography column and the flow through containing most of the cleaved PMP22 was 
collected. Successive washes with 20 mM Tris buffer (pH 8.0) containing 0.2% SCOR bicelle (q 
= 0.33), 0.3 mM DDMB, 1 mM TCEP, and increasing concentrations of imidazole (20 mM, 30 
mM, 40 mM, 250 mM) were carried out. The solution containing the cleaved PMP22 was 
concentrated before loading into a pre-equilibrated size exclusion column (GE Superdex 200 
Increase 10/300 GL). Size exclusion chromatography was performed using 10 mM acetate buffer 
(pH 5.0) containing 100 mM NaCl, 0.2 % SCOR bicelle (q = 0.33), 1 mM EDTA, 5 mM TCEP, 
and 0.3 mM DDMB to remove empty bicelles and to exchange the buffer. Fractions containing 
PMP22 were combined and concentrated using 10K MWCO Amicon concentrator for use in native 
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ion mobility-mass spectrometry experiments. The final concentration of PMP22 in SCOR bicelles 
was determined by measuring References 
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